TSS:Rfhg 160906.1

Basic information about the TSS

---

TSS ID: rfhg_160906.1 TSS ID(Version3): hg_135241.1 hg_135242.1 hg_135240.1 hg_135244.1 hg_135245.1 hg_135239.1 hg_135243.1 Species: human Chr: chr13		Start: 52652683 End: 52652915 Strand: +
Source datasets	FANTOM5|DRA000914|PRJDB5282|PRJNA4843412|DRA013844 |PRJNA401781|PRJNA548673|PRJNA615891
Protocol	CAGE|C1CAGE|NETCAGE|oligo_capping|ReCappable-seq|SLIC_CAGE |TIF-seq2|RAMPAGE
TSS cluster detected*	12

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2655925,EH38E1677931)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000483074.1:0 ENST00000310528.9:0 ENST00000343788.10:0 AJ344097:0 AK292128:0 AY321358:0 AK302363:0 AY271314:0 BC000911:0 AK291402:0 GeneID: 10910 HGNC/MGI_ID: HGNC:16987 UniProt_ID: A8K5T7 A8K7W3 B4DYC6 Q9Y2Z0 Nearer transcript ids and distances:

Gene_name: SUGT1 Gene_symbol: SUGT1 Gene_synonyms: SGT1 Gene_source: HGNC:16987

TATA-Box annotation

---

Distance to TSS:	-37
Nearest PromoterID:	NM_001130912
Entrez ID:	10910
Nearest Unigene:	Hs.281902
Nearest Refseq:	NM_006704
Nearest Ensembl:	ENSG00000165416
Gene Name:	SUGT1
Gene Alias:	SGT1
Gene Type:	protein-coding
CpG%:	0.094828
GC%:	0.678112
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):	121(GGCTATTTAGGA,-,0.00)

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SUGT1 p2@SUGT1 p3@SUGT1 p4@SUGT1 p5@SUGT1 p6@SUGT1 p7@SUGT1 p8@SUGT1
Sample		p1@SUGT1	p2@SUGT1	p3@SUGT1	p4@SUGT1	p5@SUGT1	p6@SUGT1	p7@SUGT1	p8@SUGT1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	27.47	5.45	2.14	2.92	1.36	2.53	0.97	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	26.10	3.44	2.23	3.03	2.43	1.82	0.61	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	26.04	5.40	3.28	5.02	0.96	1.16	1.16	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	26.20	2.70	1.87	3.74	1.25	0.42	0.42	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	24.52	3.15	2.02	2.70	1.57	2.02	0.67	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	29.07	3.29	2.71	3.68	0.78	1.74	0.39	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	50.11	6.32	2.83	5.01	2.40	3.27	1.31	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	34.40	7.02	1.45	3.63	0.97	1.21	1.70	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	29.71	7.05	2.35	4.27	2.56	2.35	0.85	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	32.46	5.80	2.32	4.64	0.58	2.32	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	34.36	4.85	2.02	2.02	1.21	1.62	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	31.30	5.29	1.22	2.44	2.03	0.81	1.63	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	37.56	2.42	1.93	1.45	1.29	1.13	0.81	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	24.06	1.20	2.41	1.95	1.35	0.75	0.60	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	27.01	3.29	1.10	1.32	1.54	1.10	0.22	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	23.39	2.01	1.76	1.01	2.26	1.26	0.00	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	22.71	2.40	0.87	0.66	1.53	0.66	0.66	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	19.40	2.95	2.95	0.84	1.69	2.11	1.27	3.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	24.53	1.60	1.60	1.07	1.60	1.07	0.00	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	34.15	3.31	1.96	2.41	1.50	0.30	0.00	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	32.34	2.54	1.20	1.20	0.94	1.07	0.27	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	28.31	1.55	2.07	0.86	1.90	1.04	0.35	2.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	28.95	2.84	1.68	1.81	1.42	1.29	0.13	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	28.63	4.13	0.73	1.46	0.97	0.49	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	24.25	3.10	3.35	1.81	1.81	0.52	0.77	2.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	19.31	1.90	1.90	2.22	1.27	1.27	0.32	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	28.02	2.75	1.65	1.65	2.20	0.55	0.00	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	29.70	3.06	2.59	1.18	1.18	1.18	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	26.97	2.58	1.62	1.13	2.10	0.16	0.16	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	31.13	3.26	1.81	1.27	1.27	0.72	0.90	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	25.54	1.47	1.88	2.51	2.72	1.67	0.42	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	26.96	2.15	0.78	1.37	2.15	0.78	0.20	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	25.32	2.32	1.69	1.48	0.84	1.27	0.21	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	28.37	3.96	1.15	2.64	1.48	1.15	0.66	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	24.12	1.50	1.68	1.87	2.06	0.93	1.12	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	29.13	2.68	1.72	1.53	2.11	0.96	0.19	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	25.34	2.25	2.25	1.23	1.02	1.02	0.82	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	20.95	2.42	2.42	2.42	1.41	0.81	0.20	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	27.01	1.89	2.43	2.16	2.16	0.54	1.08	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	24.97	1.92	3.84	2.64	2.64	2.16	1.20	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	18.82	2.59	1.41	1.65	1.88	0.71	0.71	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	25.62	2.34	2.34	2.20	1.76	0.88	0.44	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	25.10	2.11	2.11	1.69	2.32	1.27	0.84	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	24.30	1.92	2.62	2.80	2.27	1.75	1.22	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	29.71	5.02	3.81	2.81	2.01	1.20	1.61	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	23.26	3.49	4.42	2.56	2.33	1.86	1.63	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	22.31	2.88	1.92	2.64	3.12	1.92	1.68	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	28.61	5.36	2.68	2.68	1.19	1.79	1.79	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	26.57	2.87	2.15	2.63	3.11	1.91	2.63	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	28.71	4.45	2.83	2.63	2.02	1.82	2.43	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	30.33	3.48	3.28	2.66	3.69	1.64	1.23	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	26.24	4.00	2.67	3.78	4.23	1.56	1.78	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	153.91	27.98	0.00	0.00	0.00	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	24.49	3.19	3.55	2.48	2.13	2.13	1.42	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	20.88	1.66	1.99	2.32	2.65	1.33	1.99	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	26.85	11.75	4.19	0.00	0.84	1.68	1.68	5.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	24.34	5.05	1.38	3.21	3.21	1.38	1.84	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	28.85	1.94	1.62	3.57	2.92	2.59	1.30	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	20.88	1.61	2.57	3.21	3.53	2.25	1.28	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	21.37	4.09	6.29	2.83	3.77	1.26	1.26	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	21.15	2.82	2.82	2.12	4.94	0.71	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	18.51	2.80	2.24	2.24	1.68	0.56	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	27.07	6.37	1.59	0.80	3.98	1.59	0.80	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	23.10	4.76	4.42	1.70	4.08	2.38	1.70	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	32.82	1.95	5.85	3.25	7.47	0.65	0.32	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	23.78	1.06	4.61	0.71	1.77	0.71	1.06	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	16.16	0.00	0.00	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	110.56	31.59	0.00	0.00	15.79	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	19.50	2.44	2.44	1.95	3.41	0.98	1.95	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	23.31	3.97	2.98	2.48	2.48	1.49	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	17.83	2.35	5.63	2.35	4.69	1.41	1.88	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	28.15	4.31	1.99	4.97	2.98	1.99	1.32	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	24.75	3.40	0.31	2.78	4.02	2.47	0.62	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	31.80	2.45	2.14	3.36	1.53	2.45	2.14	1.22
Adipocyte - breast, donor1	11376-118A8	23.76	5.07	3.01	2.38	0.95	0.16	0.95	1.11
Adipocyte - breast, donor2	11327-117E4	18.61	3.21	1.76	0.80	1.93	0.80	0.80	1.28
Adipocyte - omental, donor1	11473-119C6	24.81	5.73	3.31	1.53	2.54	0.38	0.51	1.53
Adipocyte - omental, donor2	11474-119C7	20.18	5.23	2.99	1.49	1.49	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	15.07	2.68	2.68	0.67	2.34	0.33	0.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	16.59	3.19	3.19	0.64	0.64	0.00	1.28	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	9.90	2.20	0.00	0.00	3.30	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	13.10	2.71	2.26	1.81	1.35	1.35	1.35	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	12.51	1.56	1.56	0.70	1.39	0.00	0.17	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	17.01	3.32	3.32	0.98	1.96	0.39	0.59	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	16.99	3.35	2.32	2.57	1.54	1.03	0.77	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	19.79	3.07	2.23	2.79	1.67	0.28	1.39	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	15.87	1.76	5.88	1.76	3.53	0.59	0.00	1.76
Adipocyte differentiation, day08, donor1	13020-139D5	22.92	4.58	3.46	1.21	1.93	0.72	0.56	0.72
Adipocyte differentiation, day08, donor2	13023-139D8	23.56	3.55	1.29	1.29	1.29	0.32	0.00	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	5.87	2.13	3.20	0.53	1.07	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	20.03	4.45	3.90	1.11	2.23	0.00	1.11	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	15.80	5.41	2.50	0.42	2.91	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	13.06	3.01	1.51	1.76	1.51	0.25	0.75	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	12.11	1.64	3.27	0.98	3.93	0.00	0.98	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	12.79	1.22	2.13	0.61	1.83	0.30	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	11.05	0.88	0.88	2.65	0.22	0.66	0.44	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	3.23	0.36	0.36	1.08	0.72	0.00	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	0.00	0.00	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	7.20	2.34	0.18	0.54	0.18	0.36	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	3.35	0.00	0.00	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	12.33	1.85	0.62	0.21	0.21	0.41	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	32.61	6.87	2.52	2.98	1.83	0.57	1.03	2.29
Anulus Pulposus Cell, donor2	11463-119B5	18.37	3.18	0.98	1.96	1.71	0.49	0.24	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	16.17	3.15	4.04	4.94	0.90	0.90	0.90	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	23.88	6.08	0.43	3.47	4.34	1.30	1.74	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	21.40	10.70	6.42	4.28	2.14	2.14	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	17.64	1.49	2.69	2.69	2.09	1.49	1.20	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	26.56	2.53	0.00	5.06	3.79	1.26	3.79	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	23.10	3.30	1.98	2.64	0.66	1.32	1.98	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	18.19	4.22	1.62	3.57	1.95	0.65	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	18.45	3.40	1.46	1.94	2.43	0.97	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	17.82	3.56	2.97	2.38	0.59	1.78	0.59	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	19.96	3.39	1.88	3.39	1.51	2.64	1.13	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	18.87	4.35	2.18	3.63	3.63	1.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	23.82	5.02	2.51	2.51	0.00	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	23.72	3.62	2.80	2.14	2.14	0.99	1.98	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	23.20	1.36	2.73	4.09	4.09	2.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	21.71	3.17	2.71	4.37	0.75	1.36	1.96	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	12.32	3.21	3.21	4.29	0.00	2.68	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	20.41	3.97	1.70	2.65	1.13	0.94	0.94	1.32
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	22.45	1.87	2.67	4.28	1.07	0.80	1.34	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	14.63	0.00	1.95	2.93	3.90	0.98	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	22.56	3.32	3.15	3.32	0.66	1.66	0.50	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	15.61	0.00	6.00	3.60	0.00	1.20	2.40	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	0.00	7.08	10.62	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	20.41	4.46	2.40	2.23	2.23	1.37	2.06	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	29.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	18.45	2.91	1.46	3.40	3.40	0.00	1.46	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	19.73	4.93	2.28	3.04	1.90	2.28	1.52	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	19.38	2.42	3.63	1.21	0.00	1.21	3.63	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	18.81	3.42	2.28	2.28	2.85	0.57	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	21.38	4.49	1.92	2.14	1.28	0.86	1.50	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	19.36	1.81	1.03	2.84	1.81	1.03	1.03	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	18.77	3.28	2.82	3.75	0.00	1.41	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	18.97	1.29	1.93	2.89	1.29	1.93	0.96	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	17.84	1.43	2.14	0.71	4.28	1.43	1.43	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	12.87	1.17	2.34	0.58	1.75	1.75	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	19.27	1.81	2.71	5.72	2.71	0.90	2.11	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	22.57	2.38	2.38	0.00	1.19	2.38	2.38	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	18.31	4.07	1.53	3.05	4.07	1.53	1.53	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	21.90	5.35	1.27	1.02	1.78	0.51	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	19.70	1.27	1.27	4.45	0.64	0.64	1.91	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	14.24	3.88	1.73	1.29	0.86	1.29	2.59	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	16.93	1.48	1.48	2.12	1.91	0.42	1.91	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	20.01	2.32	3.77	3.77	2.03	1.74	1.45	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	20.78	2.83	5.67	4.72	1.89	1.89	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	20.17	3.05	2.20	3.05	1.19	1.02	1.36	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	27.80	6.95	2.32	0.00	4.63	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	16.90	4.23	2.11	4.23	6.34	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	14.58	1.93	2.57	3.65	1.93	1.72	1.07	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	16.85	3.01	4.21	1.20	3.01	0.60	3.01	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	16.77	3.64	2.19	2.92	0.73	0.73	1.46	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	16.09	3.91	2.99	3.91	0.46	2.30	1.38	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	17.85	0.00	2.55	0.00	2.55	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	28.47	3.81	2.29	5.59	2.54	2.80	1.78	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	21.47	5.16	1.86	2.89	1.86	1.24	1.03	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	22.95	2.75	3.98	4.59	1.22	0.61	1.22	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	23.42	1.91	2.87	5.74	0.96	0.48	0.48	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	17.74	2.22	2.66	3.33	3.10	1.55	1.77	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	6.10	1.53	4.58	1.53	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	17.72	1.66	3.32	2.22	2.22	1.66	2.22	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	18.54	4.24	3.71	2.65	1.59	0.79	1.32	1.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	21.08	1.45	3.27	2.54	1.45	0.73	1.82	0.36
Astrocyte - cerebellum, donor1	11500-119F6	10.32	1.60	0.37	0.61	0.98	0.49	0.37	0.74
Astrocyte - cerebellum, donor2	11580-120F5	6.68	1.03	0.51	0.86	0.34	0.17	0.17	0.17
Astrocyte - cerebellum, donor3	11661-122F5	3.99	0.42	0.84	0.84	0.63	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	32.42	5.93	3.49	2.09	1.74	0.35	1.74	1.74
Astrocyte - cerebral cortex, donor2	11316-117D2	36.40	5.50	1.46	5.01	1.62	0.81	1.46	2.59
Astrocyte - cerebral cortex, donor3	11392-118C6	35.80	4.33	2.39	3.43	2.68	1.19	1.19	1.04
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	81.08	8.83	2.64	5.16	3.33	0.92	1.15	4.01
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	103.11	12.40	3.26	6.39	3.63	2.38	0.88	3.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	97.98	10.36	2.39	6.03	5.80	2.05	1.37	3.53
Basophils, donor1	12241-129G9	9.15	1.05	0.00	0.26	0.00	0.26	0.52	1.05
Basophils, donor2	12242-129H1	29.95	10.10	2.89	1.80	1.44	1.08	0.00	1.44
Basophils, donor3	12243-129H2	12.64	4.70	0.15	0.88	0.29	0.29	0.44	1.03
Bronchial Epithelial Cell, donor1	11511-119G8	1.94	0.43	0.65	0.22	0.43	0.00	0.00	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	3.20	0.46	0.00	0.00	0.00	0.00	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	7.17	0.00	0.00	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	16.95	4.39	0.63	1.88	1.26	1.26	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	7.69	1.04	0.21	1.66	0.21	1.04	0.62	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	7.14	1.61	0.46	1.61	0.23	0.23	0.00	1.38
Bronchial Epithelial Cell, donor7	11769-123I5	13.86	2.34	0.90	0.72	0.90	1.08	0.00	1.08
Burkitt's lymphoma cell line:DAUDI	10422-106C8	67.71	10.72	0.82	1.85	1.24	0.62	0.41	5.36
Burkitt's lymphoma cell line:RAJI	10476-106I8	68.24	12.34	1.63	0.93	0.93	0.00	0.23	4.19
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	35.18	9.91	1.60	0.00	0.32	0.00	0.00	2.24
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	0.00	0.00	0.00	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	14.65	2.82	0.00	0.00	0.00	0.00	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	11.14	1.11	0.19	1.11	0.74	0.00	0.19	0.74
CD14+ Monocytes, donor3	11381-118B4	10.54	1.98	0.88	0.66	0.22	0.00	0.44	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	40.19	3.96	3.11	1.70	2.26	0.00	0.28	2.26
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	39.04	3.79	3.03	0.76	4.17	0.00	0.38	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	39.78	4.93	3.94	1.97	3.62	0.00	0.66	2.30
CD14+ monocytes - mock treated, donor1	11863-125A9	16.48	5.06	1.45	2.17	1.16	0.14	1.73	1.30
CD14+ monocytes - mock treated, donor2	11873-125C1	10.26	3.62	0.60	1.51	0.30	0.60	0.00	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	20.37	8.05	0.71	1.18	1.66	0.47	1.18	1.18
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	11.05	2.85	0.50	0.67	0.84	0.00	1.00	1.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	10.76	3.31	0.83	0.28	0.55	0.00	0.83	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	11.40	3.22	0.74	1.24	0.25	0.25	0.74	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	5.48	1.37	0.39	0.59	0.78	0.20	0.59	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	8.55	2.14	0.71	0.36	0.18	0.00	0.71	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	11.32	4.57	0.65	1.31	0.00	0.22	0.44	1.96
CD14+ monocytes - treated with Candida, donor1	11868-125B5	7.96	2.11	0.70	0.70	0.23	0.23	0.00	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	11.09	4.22	0.53	0.53	0.53	0.00	0.53	2.11
CD14+ monocytes - treated with Candida, donor3	11888-125D7	21.08	4.44	1.11	0.00	0.00	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	11.30	2.08	0.89	1.04	1.04	0.30	0.89	1.04
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	10.38	2.00	0.40	1.00	0.20	0.20	0.80	1.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	17.49	5.41	1.25	1.87	0.62	1.04	1.04	2.08
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	7.32	2.29	0.23	1.14	0.46	0.46	0.46	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	9.95	2.49	0.00	0.23	0.68	0.00	0.23	1.13
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	7.86	2.62	0.00	1.31	0.44	0.44	0.44	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	15.06	1.34	1.08	1.34	1.34	0.27	0.27	1.61
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	9.94	2.79	0.52	1.40	1.40	0.17	0.87	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	16.41	5.47	0.00	2.52	1.26	0.00	0.84	2.95
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	4.96	0.37	0.55	0.55	0.18	0.00	0.37	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	6.69	1.41	0.00	0.70	1.06	0.00	0.35	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	9.65	1.32	0.44	1.32	0.44	0.00	0.88	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	7.32	1.05	0.70	0.52	0.70	0.00	0.00	1.39
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	5.58	1.49	0.74	0.74	0.37	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	14.66	6.68	0.22	1.08	0.86	0.00	0.22	2.37
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	8.19	1.64	0.00	0.41	0.00	0.00	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	7.65	2.55	0.70	0.23	0.46	0.00	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	10.90	4.41	0.46	0.00	0.46	0.46	0.23	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	18.09	4.80	0.44	0.44	1.31	0.87	0.87	1.74
CD14+CD16+ Monocytes, donor2	11801-124D1	19.17	6.47	1.39	2.08	2.54	0.23	0.46	1.15
CD14+CD16+ Monocytes, donor3	11912-125G4	25.13	4.12	0.65	1.30	1.73	0.22	1.08	1.08
CD14+CD16- Monocytes, donor1	11788-124B6	35.97	7.32	1.40	1.71	2.18	0.62	0.31	2.18
CD14+CD16- Monocytes, donor2	11799-124C8	24.10	3.84	1.75	1.40	1.05	0.17	0.35	1.57
CD14+CD16- Monocytes, donor3	11910-125G2	25.86	6.91	2.23	1.78	3.12	0.45	0.67	1.56
CD14-CD16+ Monocytes, donor1	11790-124B8	31.90	6.12	1.28	1.28	1.53	1.02	0.51	1.79
CD14-CD16+ Monocytes, donor2	11800-124C9	27.88	6.15	1.98	1.10	2.20	0.44	0.88	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	32.42	6.32	1.26	0.84	0.84	0.42	0.21	2.11
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	46.74	14.23	2.03	0.00	0.00	0.00	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	50.17	10.17	2.03	0.68	0.68	0.68	0.68	4.75
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	56.96	13.46	2.07	0.00	1.04	0.00	0.00	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	41.58	17.06	1.07	1.07	3.20	0.53	0.00	5.86
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	49.32	13.40	2.68	1.07	2.68	0.00	0.54	3.22
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	43.52	8.42	1.40	2.11	2.11	0.70	0.00	2.81
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	43.92	10.98	2.35	0.78	0.78	0.00	0.78	3.92
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	56.69	17.14	2.64	1.32	6.59	0.00	1.32	2.64
CD19+ B Cells, donor1	11544-120B5	21.37	9.04	0.00	0.00	1.64	0.00	0.00	1.64
CD19+ B Cells, donor2	11624-122B4	15.23	5.08	0.73	0.73	0.73	1.45	0.73	0.73
CD19+ B Cells, donor3	11705-123B4	15.65	9.09	1.01	0.50	1.51	0.50	0.00	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	56.57	33.94	5.25	8.49	2.02	8.89	2.42	2.83
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	38.35	25.97	2.80	8.79	3.60	6.39	2.00	0.80
CD34+ Progenitors, donor1	11545-120B6	28.11	17.07	0.00	1.00	1.00	0.00	0.00	4.02
CD34+ Progenitors, donor2	11625-122B5	24.16	13.48	1.69	0.56	1.12	0.00	0.00	2.81
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	46.59	16.53	1.13	1.13	0.75	0.75	0.00	2.63
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	40.14	16.91	0.68	1.35	0.68	0.68	0.68	2.71
CD4+ T Cells, donor1	11225-116C1	24.64	10.35	1.07	1.79	0.00	0.71	1.07	1.07
CD4+ T Cells, donor2	11306-117C1	16.53	6.12	1.84	0.61	2.45	0.00	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	18.60	5.49	0.00	2.44	1.52	0.30	1.22	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	33.18	9.19	2.30	2.55	3.32	0.51	1.02	1.53
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	31.22	9.21	1.80	2.70	2.02	0.90	1.57	2.25
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	36.22	6.32	4.02	0.86	1.44	1.15	1.44	3.45
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	44.56	12.80	4.27	1.90	0.47	0.00	0.47	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	49.16	6.32	3.51	1.40	1.40	0.70	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	36.26	6.59	3.30	0.00	0.00	0.00	0.00	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	29.63	9.39	1.16	1.88	2.75	1.01	1.73	2.46
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	29.32	6.95	1.86	2.88	1.86	1.69	0.68	1.36
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	23.54	5.80	1.45	1.61	1.45	1.29	0.81	1.45
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	30.48	9.41	1.79	4.03	2.69	2.24	1.34	1.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	33.89	9.08	2.80	3.84	1.75	2.45	1.05	1.75
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	34.76	9.68	2.20	3.96	1.32	0.44	0.00	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	32.47	9.70	2.11	2.53	1.26	0.00	0.00	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	24.52	4.16	1.45	1.45	2.08	0.42	0.62	1.87
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	22.39	5.35	2.00	1.00	2.00	0.33	0.00	2.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	36.98	7.89	1.90	0.27	0.82	0.27	0.00	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	42.34	12.86	3.22	1.61	1.07	0.00	0.00	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	34.07	5.38	7.17	0.00	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	32.82	10.57	2.41	2.41	2.23	1.30	0.74	1.85
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	27.73	9.96	3.03	2.17	1.52	1.73	0.43	2.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	28.37	8.20	1.89	2.52	1.26	0.84	0.63	1.89
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	29.83	10.62	2.02	2.02	3.54	0.51	0.51	3.03
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	38.13	16.46	0.43	2.60	1.30	0.43	0.43	3.47
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	42.71	19.18	4.36	1.74	1.74	0.44	0.87	2.61
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	62.85	16.83	2.47	4.45	3.96	0.49	0.00	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	43.39	15.69	2.77	0.00	1.85	0.92	0.00	2.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	60.02	15.35	2.79	4.19	4.19	1.40	0.00	5.58
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	57.05	15.23	2.77	1.66	3.88	0.55	0.55	3.32
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	53.00	15.95	6.13	1.72	4.17	1.23	0.74	3.19
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	63.14	9.24	4.62	1.54	1.54	0.00	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	60.16	13.97	3.94	0.72	3.94	0.72	0.36	5.01
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	67.86	11.08	2.77	2.77	1.38	0.00	2.77	8.31
CD8+ T Cells, donor1	11226-116C2	24.55	7.53	0.33	0.65	0.65	0.00	0.00	2.29
CD8+ T Cells, donor2	11307-117C2	18.77	11.26	0.00	0.00	0.75	0.38	1.13	1.88
CD8+ T Cells, donor3	11383-118B6	21.71	6.56	0.50	1.01	1.01	0.25	0.50	1.51
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	19.96	6.19	0.69	1.61	1.84	2.06	2.06	1.61
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	14.86	5.51	0.96	1.44	0.72	0.72	0.96	1.20
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	25.44	4.10	0.82	2.46	1.09	1.09	0.82	1.64
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	16.51	6.90	0.60	2.40	1.50	1.20	0.60	2.10
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	17.52	5.52	0.72	1.92	1.68	1.44	0.96	1.92
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	16.14	4.78	1.14	1.59	1.14	0.23	0.23	1.14
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	27.60	10.21	1.30	2.82	0.87	1.09	0.43	1.96
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	23.43	6.05	0.79	2.63	1.58	2.90	1.05	1.32
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	27.67	7.97	3.05	3.28	1.64	0.23	0.23	1.88
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	26.57	7.25	0.60	3.32	1.21	0.60	1.21	2.11
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	27.89	6.10	1.16	1.16	1.45	0.87	1.45	1.45
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	24.25	7.46	0.80	3.46	1.07	0.80	1.07	2.40
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	19.70	4.82	0.00	2.19	0.88	0.88	0.88	2.19
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	12.30	9.11	0.46	3.64	0.46	0.46	0.46	2.73
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	17.16	4.48	0.75	2.98	0.00	0.00	0.00	2.98
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	10.08	5.76	1.44	3.96	0.72	1.44	0.36	1.80
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	15.25	3.45	1.44	1.44	0.86	1.44	0.86	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	15.79	4.01	2.12	2.36	0.47	0.47	0.24	2.12
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	32.32	12.68	2.85	2.54	0.95	2.22	0.63	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	25.53	5.84	0.62	2.46	1.85	0.92	0.92	2.15
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	24.36	8.98	0.64	2.89	0.32	0.32	0.64	1.60
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	19.89	8.41	1.53	2.29	1.53	0.76	0.00	3.44
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	20.49	5.12	0.79	2.36	1.58	2.36	0.00	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	23.45	8.32	2.27	0.76	0.76	0.00	0.00	2.27
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	33.72	7.23	0.00	4.82	1.61	0.80	0.00	4.01
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	44.06	10.49	2.80	2.10	0.00	2.80	0.70	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	39.07	4.01	1.00	4.01	2.00	1.00	0.00	3.01
Cardiac Myocyte, donor1	11525-119I4	12.79	7.31	3.66	0.00	0.00	0.00	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	18.28	3.95	0.99	0.49	0.00	1.48	0.49	0.99
Cardiac Myocyte, donor3	11686-122I3	21.78	6.00	1.58	1.58	0.74	1.05	0.63	1.58
Chondrocyte - de diff, donor1	11261-116G1	30.51	9.01	2.43	4.85	1.04	1.39	2.08	1.04
Chondrocyte - de diff, donor2	11338-117F6	10.66	1.78	1.07	0.71	1.42	1.07	0.36	1.78
Chondrocyte - de diff, donor3	11410-118E6	23.78	5.80	1.48	1.71	1.93	0.57	0.57	1.48
Chondrocyte - re diff, donor2	11339-117F7	16.11	8.95	4.48	2.69	3.58	0.00	0.90	1.79
Chondrocyte - re diff, donor3	11411-118E7	16.18	3.64	0.40	2.43	1.21	0.81	0.81	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	35.69	4.82	2.87	3.10	1.72	1.38	1.72	1.15
Ciliary Epithelial Cells, donor2	11323-117D9	25.87	5.13	2.35	4.49	1.92	0.43	1.71	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	27.61	5.49	1.42	2.92	1.86	0.80	0.53	1.33
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	29.99	7.98	3.03	1.01	3.94	0.55	0.37	0.55
Corneal Epithelial Cells, donor1	11526-119I5	1.98	0.66	0.22	0.00	0.00	0.22	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	2.28	1.14	0.00	1.14	0.00	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	5.37	1.02	0.51	0.00	0.00	0.51	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	39.13	4.62	1.32	0.99	0.50	0.33	0.33	1.16
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	32.49	4.10	1.26	0.95	1.89	0.32	0.63	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	37.96	0.00	0.00	0.00	6.90	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	24.19	4.43	1.30	0.86	1.08	0.54	0.32	0.97
Dendritic Cells - plasmacytoid, donor1	11228-116C4	34.85	5.12	1.02	2.05	0.34	1.02	0.34	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	29.38	4.57	2.61	3.26	0.65	0.00	0.65	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	33.39	5.32	0.97	3.39	0.97	0.00	1.45	1.94
Endothelial Cells - Aortic, donor0	11207-116A1	14.18	2.84	0.50	1.67	0.33	1.00	1.33	1.00
Endothelial Cells - Aortic, donor1	11263-116G3	7.63	0.00	0.00	2.93	1.76	1.17	1.76	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	9.33	2.55	1.13	1.41	0.57	0.57	0.85	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	11.80	1.97	0.79	4.33	0.79	0.39	1.97	0.39
Endothelial Cells - Artery, donor1	11264-116G4	15.13	2.62	0.87	2.33	0.87	1.45	0.58	0.87
Endothelial Cells - Artery, donor2	11341-117F9	32.47	4.94	1.65	5.18	1.18	0.94	2.59	0.94
Endothelial Cells - Artery, donor3	11413-118E9	14.02	2.63	0.88	2.28	0.35	1.23	1.40	1.58
Endothelial Cells - Lymphatic, donor1	11236-116D3	32.36	4.43	3.32	2.44	3.32	1.33	0.89	1.33
Endothelial Cells - Lymphatic, donor2	11317-117D3	30.43	5.17	1.52	2.13	2.43	1.22	1.22	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	28.47	7.89	0.85	1.13	1.97	0.56	0.85	1.13
Endothelial Cells - Microvascular, donor1	11265-116G5	12.78	1.49	0.59	0.89	0.89	0.00	0.59	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	13.02	1.56	0.52	3.12	1.04	0.00	1.56	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	7.51	1.42	0.14	0.85	0.85	0.00	0.43	0.71
Endothelial Cells - Thoracic, donor1	11266-116G6	38.01	8.40	1.60	6.40	1.60	2.40	1.20	2.40
Endothelial Cells - Thoracic, donor2	11343-117G2	15.20	3.14	1.05	1.57	0.00	1.05	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	65.73	12.80	2.36	7.21	3.23	2.61	3.35	3.98
Endothelial Cells - Umbilical vein, donor2	11324-117E1	47.36	7.82	1.96	6.30	1.52	0.43	1.74	2.17
Endothelial Cells - Umbilical vein, donor3	11400-118D5	45.92	7.57	2.69	9.40	2.56	1.95	3.66	1.22
Endothelial Cells - Vein, donor1	11267-116G7	7.96	4.55	2.28	3.41	1.14	2.28	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	11.87	2.79	0.70	1.40	0.70	1.40	2.10	0.00
Endothelial Cells - Vein, donor3	11416-118F3	16.64	2.51	0.47	3.30	0.63	0.94	1.88	0.63
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	4.95	1.65	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	3.57	3.57	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	2.93	0.24	0.24	0.24	0.00	0.00	0.49	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	25.45	5.34	2.46	1.23	2.05	1.23	0.41	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	14.23	1.64	1.97	2.30	1.97	1.75	0.99	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	21.99	4.01	2.38	3.47	2.17	2.17	1.41	1.73
Fibroblast - Aortic Adventitial, donor1	11245-116E3	34.93	8.13	2.43	1.46	1.82	0.61	0.85	2.67
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	34.80	4.09	5.19	3.82	1.77	3.00	1.77	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	20.99	3.59	2.95	2.43	2.00	0.84	0.95	1.37
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	20.82	5.53	3.16	1.84	2.90	2.37	1.58	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	29.23	7.64	1.99	4.65	1.33	1.99	1.33	1.33
Fibroblast - Cardiac, donor1	11268-116G8	15.88	0.91	0.45	0.91	2.72	0.91	0.00	1.36
Fibroblast - Cardiac, donor2	11345-117G4	12.89	3.03	0.76	0.76	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	19.71	4.26	0.95	1.10	0.63	0.32	0.32	0.79
Fibroblast - Cardiac, donor4	11452-119A3	30.92	6.67	3.64	1.52	2.12	0.61	0.91	1.82
Fibroblast - Cardiac, donor5	11456-119A7	29.82	5.58	1.90	3.17	2.54	1.40	1.14	2.66
Fibroblast - Cardiac, donor6	11460-119B2	28.65	4.85	1.67	5.76	1.06	1.21	2.12	2.12
Fibroblast - Choroid Plexus, donor1	11492-119E7	9.38	1.88	0.80	0.80	0.27	0.00	0.80	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	24.59	3.88	0.86	0.43	0.86	1.29	0.00	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	19.04	0.00	4.39	0.00	1.46	1.46	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	7.38	1.61	0.23	0.00	0.00	0.00	0.00	2.77
Fibroblast - Conjunctival, donor3	11692-122I9	27.65	6.95	1.87	1.36	2.37	0.85	0.51	2.37
Fibroblast - Dermal, donor1	11269-116G9	22.77	3.05	3.99	2.82	0.47	2.11	0.70	0.23
Fibroblast - Dermal, donor2	11346-117G5	12.26	2.36	0.47	2.83	0.00	0.00	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	28.05	4.35	2.06	2.30	1.69	0.60	0.48	0.85
Fibroblast - Dermal, donor4	11450-119A1	30.30	4.07	2.15	4.07	1.47	2.60	0.79	1.70
Fibroblast - Dermal, donor5	11454-119A5	37.16	4.19	2.44	6.45	2.09	1.92	0.87	1.74
Fibroblast - Dermal, donor6	11458-119A9	43.69	5.85	3.25	7.15	3.57	3.09	2.27	1.62
Fibroblast - Gingival, donor1	11237-116D4	26.03	7.50	2.50	1.04	2.08	2.71	0.62	2.08
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	44.80	6.55	2.62	1.31	3.14	0.79	0.79	1.05
Fibroblast - Gingival, donor2	11318-117D4	34.26	6.72	3.43	5.53	2.64	1.84	1.84	1.32
Fibroblast - Gingival, donor3	11394-118C8	21.95	5.99	1.26	1.74	2.42	0.10	0.19	2.03
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	27.01	7.27	1.04	5.19	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	24.67	3.00	2.82	1.94	2.11	1.06	1.06	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	43.18	5.46	3.90	4.52	2.49	1.25	1.25	2.03
Fibroblast - Gingival, donor6 (control)	11922-125H5	34.21	6.49	2.16	4.33	1.89	0.81	1.49	1.62
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	15.17	3.18	1.06	4.59	2.12	0.71	1.06	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	30.57	5.41	2.49	7.31	3.66	3.07	2.63	1.17
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	41.86	9.54	3.00	5.32	4.77	1.36	1.77	1.77
Fibroblast - Gingival, donor8 (control)	11926-125H9	39.05	6.91	2.96	6.14	1.97	3.84	1.32	2.08
Fibroblast - Gingival, donor9 (control)	11927-125I1	29.49	4.11	2.49	2.35	3.52	1.17	0.29	2.49
Fibroblast - Lung, donor1	11270-116H1	8.16	1.36	0.00	0.00	0.00	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	31.34	10.45	1.49	5.97	0.00	0.00	0.00	2.98
Fibroblast - Lung, donor3	11419-118F6	36.30	5.28	1.69	3.59	1.69	2.53	0.84	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	5.00	1.67	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	5.59	0.00	1.40	0.00	0.00	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	0.56	0.00	0.28	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	13.80	2.03	1.22	0.41	0.41	1.22	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	0.00	7.99	0.00	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	37.05	9.70	2.91	5.82	1.75	3.49	2.33	2.13
Fibroblast - Periodontal Ligament, donor2	11319-117D5	49.45	5.01	3.49	5.31	4.25	2.12	2.58	2.28
Fibroblast - Periodontal Ligament, donor3	11395-118C9	34.58	7.65	2.14	1.84	1.84	1.84	1.53	2.14
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	19.84	3.43	2.29	3.05	1.91	1.91	1.53	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	29.16	6.48	2.97	1.89	1.89	0.00	1.08	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	27.02	4.29	2.32	2.09	1.97	0.35	0.12	1.62
Fibroblast - Pulmonary Artery, donor1	11250-116E8	38.47	9.84	2.43	4.09	2.21	1.11	2.87	2.21
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	9.55	1.63	0.61	1.42	0.20	0.41	0.41	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	5.35	2.00	0.00	0.00	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	19.77	7.12	1.98	1.19	2.37	0.40	0.40	2.77
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	38.90	7.14	5.16	1.98	2.58	0.40	0.60	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	18.29	5.51	2.49	1.60	2.66	0.71	0.53	1.07
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	24.24	6.11	3.15	2.17	1.38	0.59	0.59	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	30.99	4.81	3.01	2.11	2.41	3.61	1.81	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	32.39	7.88	3.13	3.67	2.59	1.30	1.84	2.16
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	34.92	8.10	4.30	1.77	5.06	1.01	1.52	1.27
Fibroblast - skin normal, donor1	11553-120C5	21.33	6.07	1.97	1.80	0.66	0.49	0.33	0.82
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	48.12	7.82	3.61	3.41	1.60	2.01	1.20	1.00
Fibroblast - skin normal, donor2	11561-120D4	34.06	7.23	3.62	3.11	3.21	0.90	1.91	1.51
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	44.13	6.65	4.84	2.72	4.84	2.42	2.42	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	24.36	3.81	4.14	3.48	1.66	0.66	0.83	0.99
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	27.52	7.01	4.10	2.39	1.71	0.68	0.68	1.71
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	33.17	5.91	3.94	0.66	2.96	1.31	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	36.22	8.84	3.09	5.01	2.88	1.60	2.02	2.24
Fibroblast - skin walker warburg, donor1	11554-120C6	19.90	6.58	2.19	2.70	1.01	1.18	1.35	1.86
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	22.27	6.27	0.78	1.10	2.67	0.47	0.31	2.20
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	110.80	110.80	22.16	0.00	0.00	0.00	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	40.96	11.33	6.10	1.74	5.23	0.87	0.87	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	24.62	4.85	2.95	4.16	1.56	2.25	2.08	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	26.28	3.38	2.60	2.86	0.78	1.56	0.78	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	24.53	4.85	1.53	3.32	1.02	1.53	1.53	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	45.17	7.66	2.30	13.78	1.53	4.59	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	41.47	7.02	3.83	9.57	3.19	2.55	2.55	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	61.62	8.84	3.71	22.82	3.42	9.98	3.99	2.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	49.64	7.17	1.10	3.03	4.41	1.10	0.83	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	47.95	5.48	1.60	4.79	3.88	0.68	1.60	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	46.56	5.94	3.96	20.21	2.58	6.14	5.15	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	52.60	6.34	1.59	1.32	4.49	1.59	0.53	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	57.40	4.24	2.61	1.96	3.59	0.33	0.33	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	35.38	9.29	7.08	24.76	3.54	4.42	8.40	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	47.06	8.90	1.27	4.52	2.40	1.27	0.57	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	44.95	7.27	1.72	3.69	1.35	1.85	1.85	1.72
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	37.88	9.67	4.03	3.22	0.81	3.76	1.07	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	33.95	5.70	2.60	4.46	1.61	0.62	1.86	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	29.62	5.95	1.94	5.54	1.94	0.55	0.69	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	27.85	6.71	2.24	4.47	1.42	1.63	2.44	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	33.09	6.62	1.60	3.19	0.91	0.46	0.00	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	40.11	4.36	1.12	2.99	2.74	0.37	0.75	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	30.38	3.72	1.75	4.81	1.31	1.09	0.22	1.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	41.07	4.43	2.07	2.07	2.07	0.30	0.59	1.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	29.73	6.99	1.43	3.34	1.59	0.79	0.64	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	31.28	5.14	1.79	2.46	2.68	2.01	0.89	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	31.66	5.04	1.81	2.62	2.22	0.60	0.60	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	36.30	5.94	0.85	1.53	1.87	0.51	1.19	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	44.78	8.87	2.75	3.72	1.51	0.71	0.53	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	43.70	3.75	1.25	1.14	1.77	0.52	0.31	0.94
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	32.45	7.51	2.05	2.05	0.85	0.17	0.17	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	36.63	5.64	1.55	2.43	2.21	0.66	0.11	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	41.27	7.40	2.33	1.75	0.75	1.16	0.75	1.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	38.59	8.78	1.84	1.63	2.04	1.02	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	35.90	4.75	1.24	1.65	0.83	0.62	0.00	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	34.93	4.73	0.92	1.61	1.61	0.12	0.12	1.15
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	37.36	5.67	1.00	2.33	1.67	0.83	0.17	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	36.81	3.31	2.20	0.44	1.54	0.44	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	43.29	3.94	0.86	1.11	2.71	0.37	0.37	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	36.31	4.86	1.30	1.46	2.11	0.32	0.65	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	44.26	3.53	2.25	1.28	0.96	0.64	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	30.04	3.88	1.33	1.71	2.18	0.38	0.66	0.85
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	31.48	3.80	1.58	1.42	1.11	0.63	0.79	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	25.85	6.39	1.52	0.61	1.52	0.30	1.22	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	31.78	6.90	0.84	1.78	2.72	0.94	0.84	1.05
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	30.74	3.95	1.54	1.76	0.88	0.66	0.22	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	35.07	3.93	1.40	1.68	1.68	0.28	0.00	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	28.15	5.00	1.39	1.76	1.94	0.28	0.83	1.02
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	29.15	5.35	1.34	2.67	1.87	0.27	2.41	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	32.59	7.34	2.30	1.84	2.14	1.38	0.92	1.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	32.51	6.61	1.17	2.72	1.55	1.30	0.78	0.91
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	35.51	4.88	1.08	2.44	1.36	0.54	1.08	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	28.94	4.98	1.66	1.47	0.92	0.37	0.74	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	31.58	5.26	1.10	1.54	2.19	0.44	0.66	1.97
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	23.80	3.97	1.98	0.99	1.98	1.98	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	27.31	5.67	1.85	1.06	1.06	0.13	0.40	1.19
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	25.42	4.24	1.82	1.41	1.61	1.01	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	27.96	4.83	1.27	0.51	2.03	0.76	0.25	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	61.71	16.72	3.98	16.12	1.99	4.38	3.78	2.39
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	47.92	11.09	0.92	4.16	0.92	1.54	0.77	0.92
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	54.21	13.91	3.68	9.21	3.68	1.43	1.43	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	51.01	10.95	2.19	6.57	2.19	1.56	3.76	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	49.73	9.89	3.39	11.02	2.26	2.26	1.70	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	54.42	10.15	3.23	5.07	2.31	3.69	0.92	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	84.14	7.42	4.95	4.95	7.42	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	59.18	15.09	3.48	5.42	1.93	0.77	1.55	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	54.55	6.42	4.81	1.60	1.60	3.21	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	71.29	17.39	1.74	3.48	6.96	1.74	1.74	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	53.38	8.79	1.95	4.88	2.93	1.30	1.63	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	48.59	8.24	2.47	4.53	2.06	1.24	1.24	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	6.66	3.33	0.00	0.00	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	51.73	8.67	1.12	2.24	2.52	0.56	0.56	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	49.68	10.13	4.25	4.58	3.60	0.33	1.63	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	38.59	5.87	2.52	2.52	1.68	1.68	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	56.62	9.22	2.86	2.54	1.59	1.59	0.64	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	47.55	9.85	1.02	4.76	4.42	1.02	0.68	2.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	64.73	6.26	4.18	2.09	4.18	2.09	0.00	6.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	46.39	6.87	3.44	2.29	3.44	0.57	0.57	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	28.12	3.26	2.37	2.07	2.96	0.59	0.30	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	66.07	13.55	3.39	5.08	1.69	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	48.88	9.53	2.07	2.07	4.97	0.00	1.24	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	43.72	10.13	2.07	2.76	2.99	0.23	0.23	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	57.95	10.54	10.54	0.00	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	37.67	5.38	2.69	1.92	1.54	0.00	0.38	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	41.07	8.15	3.91	2.28	2.28	0.65	0.33	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	69.56	6.69	4.01	2.68	2.68	2.01	2.68	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	41.61	3.85	1.54	2.31	2.31	0.39	0.00	3.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	45.53	10.61	3.08	4.45	1.71	2.40	1.03	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	62.12	2.48	0.00	2.48	0.00	0.00	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	54.26	2.83	2.36	2.36	3.30	0.47	0.94	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	34.40	1.81	3.02	4.22	1.81	1.21	0.60	3.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	35.10	5.60	0.51	3.05	2.03	2.03	0.51	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	43.07	9.57	2.79	1.99	3.59	0.40	0.40	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	57.23	5.43	2.96	2.96	3.95	0.49	0.49	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	57.84	9.44	0.00	2.36	7.08	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	48.43	7.58	1.75	5.83	3.50	0.58	0.58	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	50.91	5.27	1.76	4.83	1.76	0.44	0.00	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	39.84	5.93	3.39	2.54	2.54	0.85	2.54	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	28.05	8.36	1.79	1.19	3.58	0.60	0.00	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	39.31	8.25	2.43	3.88	2.43	0.00	0.49	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	18.26	1.14	0.00	2.28	0.00	0.00	1.14	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	25.36	3.33	1.66	0.83	1.25	0.00	0.00	1.66
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	11.24	0.00	0.00	4.50	0.00	1.12	3.37	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	16.18	2.22	2.22	1.27	1.59	0.95	0.00	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	9.19	0.42	1.67	0.84	0.00	0.42	0.42	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	23.67	6.85	1.16	2.20	0.81	1.51	0.81	1.16
Hep-2 cells mock treated, biol_rep2	11899-125E9	26.16	6.58	2.53	2.70	1.18	1.52	0.51	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	22.75	6.37	1.82	2.05	1.37	1.59	0.23	1.59
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	26.89	6.23	1.53	2.73	1.42	1.09	0.22	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	21.06	6.02	0.86	1.93	1.07	0.64	0.43	1.29
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	22.17	8.40	1.29	1.72	1.08	1.51	0.22	1.08
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	28.52	4.73	1.25	1.49	1.12	0.62	0.12	1.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	21.96	6.69	1.54	2.23	0.51	0.86	1.03	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	14.42	4.49	1.28	0.96	1.28	0.64	0.64	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	16.79	1.68	0.56	1.12	0.56	0.00	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.90	0.87	0.00	1.30	0.43	0.87	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	50.23	7.93	0.00	0.00	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	5.64	1.06	2.12	0.71	0.00	0.35	0.71	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	4.36	0.73	0.00	0.00	0.00	0.73	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	24.13	7.52	2.45	1.40	1.22	0.70	2.10	0.87
Hepatocyte, donor1	11523-119I2	21.79	18.16	2.42	3.63	1.21	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	14.01	7.54	2.15	0.00	1.08	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	24.54	4.91	3.07	0.00	2.45	0.00	0.00	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	63.31	9.79	3.92	2.61	1.96	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	41.95	9.09	2.62	1.92	1.57	1.22	0.35	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	23.33	3.70	1.92	4.25	1.51	1.65	2.33	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	0.00	0.00	0.00	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	6.92	2.77	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	0.00	2.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	2.56	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	4.57	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	9.75	6.50	0.00	0.00	0.00	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	3.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	17.21	0.00	1.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	8.87	1.11	0.00	1.11	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	5.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	13.86	4.41	0.00	0.00	0.00	0.00	0.63	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	4.64	3.09	0.00	0.00	0.00	0.00	0.00	4.64
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	6.46	3.23	0.00	1.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	8.05	0.00	1.61	1.61	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	8.96	0.81	0.00	2.44	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	5.46	1.26	0.00	0.00	0.00	0.00	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	13.66	0.80	0.00	0.80	1.61	0.00	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	9.23	2.77	0.00	0.00	1.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	9.44	2.36	0.00	0.00	0.94	0.47	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	9.07	0.91	0.00	0.91	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	16.14	3.23	0.00	2.15	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	8.89	0.00	0.00	1.27	0.00	1.27	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	8.29	0.64	0.64	0.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	10.94	1.82	0.00	0.00	0.00	0.00	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	7.85	1.43	0.71	0.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	13.27	1.85	0.00	1.54	0.31	0.00	0.31	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	8.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	3.14	0.00	0.00	0.00	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	10.43	0.70	0.70	0.70	0.70	0.00	1.39	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4.43	2.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	3.24	0.00	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	11.34	0.87	0.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	2.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	7.47	1.07	0.00	0.00	0.00	0.00	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	12.47	0.00	0.00	0.00	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	0.00	2.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	11.05	0.92	0.00	2.76	0.00	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	0.00	3.03	0.00	3.03	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	3.17	0.00	0.00	1.06	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	19.67	5.14	1.39	1.71	0.98	0.90	0.41	0.41
Keratinocyte - epidermal, donor2	11349-117G8	1.76	2.34	0.00	0.00	0.00	0.00	0.00	1.17
Keratinocyte - epidermal, donor3	11421-118F8	18.17	5.21	0.57	2.56	1.14	1.61	0.76	0.66
Keratinocyte - oral, donor1	11251-116E9	30.31	6.92	1.59	1.36	1.02	1.02	0.23	1.48
Keratocytes, donor1	11527-119I6	7.56	2.41	0.00	0.34	0.00	0.00	0.00	1.03
Keratocytes, donor2	11607-120I5	3.52	0.00	0.00	4.69	0.00	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	20.75	1.58	1.19	1.38	0.99	0.40	0.20	1.78
Krukenberg tumor cell line:HSKTC	10687-109F3	13.19	0.00	4.40	2.20	4.40	0.00	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	22.65	3.24	4.31	4.31	0.00	1.08	1.08	1.08
Lens Epithelial Cells, donor2	11609-120I7	29.06	2.42	2.08	1.96	1.15	0.81	0.35	1.15
Lens Epithelial Cells, donor3	11690-122I7	31.79	5.65	1.92	2.32	1.01	0.81	0.30	1.11
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	19.09	3.56	0.71	1.30	1.30	0.12	0.24	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	11.72	3.63	1.40	0.28	0.84	0.28	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	31.17	5.19	1.57	1.73	1.89	0.63	1.10	1.42
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	13.44	4.30	0.54	2.15	0.54	0.00	0.00	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	8.19	2.52	0.32	2.52	0.00	0.00	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	11.54	2.37	0.65	0.75	0.54	0.32	0.43	0.75
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	15.59	5.34	2.46	2.05	0.00	0.41	0.41	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	5.56	0.25	0.00	0.51	0.00	0.00	0.25	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	10.70	3.52	1.13	0.99	0.84	0.28	0.42	0.99
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	19.78	3.96	0.79	0.79	0.40	0.40	1.19	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	18.23	4.46	0.39	1.55	0.58	0.00	0.39	1.16
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	4.63	2.04	0.19	0.56	0.19	0.19	0.56	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	13.94	7.67	1.39	1.39	0.70	0.00	0.70	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	14.55	1.91	0.24	0.72	1.19	0.48	0.24	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.48	2.88	0.27	0.69	0.82	0.00	0.41	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	19.71	4.93	0.92	1.85	1.23	0.00	1.54	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	5.92	1.56	0.00	0.31	0.62	0.31	0.94	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	8.78	2.20	0.18	0.55	0.91	0.18	0.37	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	13.82	4.28	0.99	0.66	0.99	0.66	0.33	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	5.86	2.05	0.00	1.17	0.29	0.00	0.59	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	6.72	0.50	0.00	0.25	0.50	0.00	0.50	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	24.73	3.39	0.00	1.94	0.48	0.48	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	15.08	4.04	0.81	1.35	0.27	0.27	0.81	1.62
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	10.45	3.63	0.91	1.21	0.45	0.00	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	10.37	1.56	0.00	1.56	0.00	0.00	0.52	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	20.73	3.56	0.63	1.47	1.05	0.42	0.21	1.05
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	7.82	2.41	0.15	0.90	0.15	0.15	0.45	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	17.20	2.75	0.69	2.06	1.38	0.69	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	13.36	2.63	0.19	0.75	0.38	0.38	0.75	1.13
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	6.36	1.80	0.32	0.85	0.32	0.00	0.32	0.53
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	18.41	4.85	0.48	2.91	0.00	0.48	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	17.20	2.32	0.66	1.98	1.32	0.00	0.33	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	7.68	1.98	0.37	0.62	0.25	0.12	0.50	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	25.91	7.03	1.11	0.37	0.74	0.00	0.74	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	12.60	2.96	0.74	1.98	0.74	0.00	0.25	1.98
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	6.87	0.82	0.69	0.96	0.27	0.14	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	19.94	5.15	0.64	2.57	0.96	0.64	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	21.00	5.48	0.00	0.91	0.61	0.61	0.00	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	18.62	5.60	0.42	1.68	0.28	0.00	0.84	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	18.49	4.98	1.42	1.78	1.78	0.00	0.71	1.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	7.27	1.45	0.00	1.45	0.00	0.48	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	4.67	0.93	0.16	0.31	0.31	0.31	0.16	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	22.56	5.73	1.07	1.79	1.07	0.72	0.72	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	15.03	1.96	0.33	1.96	0.33	0.00	0.65	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.71	1.65	0.47	0.47	0.00	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	22.89	6.81	0.25	0.99	0.99	0.25	0.74	1.49
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	6.92	1.28	0.26	1.54	0.00	0.00	0.00	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5.07	1.49	0.30	0.00	0.90	0.30	0.30	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	6.80	2.27	2.27	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	11.51	1.53	0.77	0.00	1.53	1.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	9.65	3.71	0.00	0.00	0.74	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	8.04	5.50	0.85	0.00	0.42	0.00	0.00	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	9.85	3.52	0.00	0.00	0.00	0.00	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	4.67	0.00	0.00	0.00	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	9.79	2.58	0.00	0.52	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	4.76	0.00	1.19	0.00	0.00	0.00	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	9.95	3.62	0.68	0.68	0.90	0.00	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	13.96	2.62	0.87	0.29	0.87	0.29	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	14.86	1.80	0.45	0.00	0.45	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	9.89	2.17	0.41	0.81	0.54	0.00	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	9.76	3.08	0.51	1.03	0.51	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	11.29	4.23	0.71	0.71	0.71	0.00	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	6.00	2.67	0.00	0.67	1.33	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	8.15	1.02	1.53	0.00	1.02	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	14.94	4.00	0.27	0.27	1.07	0.53	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	11.34	4.16	1.51	0.19	1.32	0.38	0.57	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	10.43	1.23	0.61	0.61	0.00	0.00	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	11.42	0.82	1.63	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	12.91	5.62	0.42	0.83	0.83	0.00	0.42	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	11.21	5.61	0.84	0.00	0.84	0.28	0.28	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	7.21	2.06	0.00	0.00	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	11.90	4.94	0.87	0.58	1.16	0.00	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	10.46	4.48	0.60	0.30	1.49	0.30	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	9.41	4.43	1.11	0.55	0.55	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	11.31	3.18	1.77	0.71	0.00	0.00	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	8.48	1.48	0.37	0.37	0.37	0.74	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	5.76	3.45	1.15	0.00	0.00	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	9.21	4.22	0.77	0.00	1.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	11.32	2.26	0.57	0.00	0.57	0.00	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	6.56	1.64	1.64	0.82	0.82	0.00	0.00	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	7.23	1.36	0.90	1.81	1.36	0.00	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	7.18	4.31	0.00	0.72	0.72	0.00	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	11.95	2.99	0.00	0.00	1.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	10.03	3.72	1.49	0.74	0.37	0.37	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	10.34	2.58	0.43	0.00	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	6.85	2.57	0.86	0.00	0.00	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	12.66	4.33	1.33	0.33	2.33	0.00	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	7.84	1.21	0.00	1.21	1.21	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	10.66	0.71	0.00	1.42	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	11.34	2.41	1.03	0.69	0.69	0.69	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	4.83	2.15	1.07	0.54	0.00	0.54	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	6.73	4.04	2.02	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	12.96	1.11	0.00	0.74	0.74	0.37	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	11.63	1.16	2.33	1.16	0.00	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	7.40	1.06	0.00	0.00	1.06	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	10.40	1.20	0.00	0.40	0.40	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	8.72	0.73	0.73	0.73	0.73	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	9.20	1.53	0.00	0.77	0.77	0.77	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	6.41	2.47	0.49	0.00	0.49	0.49	0.99	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	7.53	2.82	0.00	0.00	0.00	0.00	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	7.54	0.50	0.00	2.01	0.00	0.00	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	7.66	2.25	0.90	0.45	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	8.61	0.00	1.72	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	8.02	3.56	0.89	0.00	0.45	0.00	0.89	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	10.17	2.35	0.00	0.39	0.00	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	5.28	2.64	1.98	0.66	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	4.67	2.59	0.52	0.52	0.00	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	6.13	2.19	0.00	0.88	0.44	0.00	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	8.39	3.35	1.12	1.12	1.68	1.12	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	7.95	4.86	1.32	0.00	0.00	0.00	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	9.64	2.70	0.77	0.00	0.39	0.00	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	6.58	2.03	0.00	0.51	0.00	0.00	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	7.21	3.36	1.44	0.96	0.48	0.00	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	7.55	1.19	0.80	0.40	0.00	0.00	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	7.29	0.61	0.61	0.00	0.00	0.61	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	4.84	5.53	0.00	0.00	0.69	1.38	0.00	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	6.84	2.66	0.38	0.38	0.38	0.00	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	9.30	2.07	1.03	0.52	0.52	0.52	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	6.65	2.42	0.00	0.00	0.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	7.29	2.85	0.95	0.63	0.63	0.00	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	10.13	1.60	0.00	1.07	0.53	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	6.32	1.15	0.57	0.57	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	7.71	1.54	0.51	1.03	2.06	0.00	0.51	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	9.20	2.83	0.71	0.71	0.71	0.00	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	6.24	2.27	0.57	1.70	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	5.82	2.50	0.83	0.42	0.83	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	7.83	1.57	1.57	0.00	0.78	0.00	0.78	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	10.02	2.09	0.42	0.42	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	13.94	2.79	0.46	0.46	0.93	0.46	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	6.69	2.68	0.00	0.00	2.01	0.67	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	10.16	2.14	1.60	0.00	0.00	0.00	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	7.68	3.23	0.40	0.00	0.40	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	7.34	0.92	0.00	1.84	0.92	0.00	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	4.45	1.78	0.00	1.78	1.78	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	6.84	2.85	1.14	0.00	0.57	0.00	0.57	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	9.20	0.77	0.77	1.53	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	8.75	3.28	0.55	1.64	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	8.02	2.67	0.00	0.45	0.89	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	12.74	1.82	0.26	0.52	0.78	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	6.63	0.66	0.66	0.00	0.00	0.00	0.00	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	8.31	0.00	2.08	4.16	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	29.86	2.73	1.60	1.14	0.91	0.23	0.23	1.82
Macrophage - monocyte derived, donor2	11313-117C8	23.86	3.12	2.57	1.10	0.73	0.55	0.37	0.92
Macrophage - monocyte derived, donor3	11389-118C3	20.58	3.80	1.84	1.05	1.31	0.79	0.79	0.92
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	29.21	5.84	3.19	3.19	1.06	0.53	2.66	0.53
Mallassez-derived cells, donor2	11929-125I3	29.00	7.29	2.85	2.38	2.22	0.48	0.79	0.79
Mallassez-derived cells, donor3	11930-125I4	30.44	6.12	2.64	3.75	1.39	2.22	2.08	0.83
Mammary Epithelial Cell, donor1	11273-116H4	45.44	10.46	1.49	2.39	0.40	0.10	0.40	3.09
Mammary Epithelial Cell, donor2	11350-117G9	30.11	8.98	0.87	1.45	0.29	1.16	0.00	2.90
Mammary Epithelial Cell, donor3	11422-118F9	13.97	1.25	0.25	1.50	0.75	0.50	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	96.27	15.59	2.71	1.36	4.75	0.68	1.36	8.14
Mast cell, donor1	11563-120D6	25.52	7.89	0.43	0.87	1.08	0.00	0.22	5.30
Mast cell, donor2	11565-120D8	35.36	10.10	1.19	1.49	1.49	0.30	0.30	2.97
Mast cell, donor3	11566-120D9	34.22	10.58	1.35	1.35	2.03	0.45	0.45	2.25
Mast cell, donor4	11567-120E1	37.23	11.70	2.13	1.42	1.77	0.00	0.71	1.95
Mast cell, expanded and stimulated, donor5	11940-126A5	41.47	9.65	1.55	0.55	2.11	0.11	0.44	3.88
Mast cell, expanded and stimulated, donor8	11942-126A7	33.85	13.42	1.17	1.75	0.58	0.00	0.00	2.33
Mast cell, expanded, donor5	11939-126A4	30.40	6.08	1.95	0.34	1.49	0.23	0.69	3.44
Mast cell, expanded, donor8	11941-126A6	29.62	8.37	1.34	1.34	1.34	0.17	0.67	2.85
Melanocyte - dark, donor1	11502-119F8	41.49	11.54	0.90	1.89	1.19	0.20	1.29	2.29
Melanocyte - dark, donor2	11582-120F7	18.34	4.50	1.04	1.73	1.04	0.69	0.69	1.04
Melanocyte - dark, donor3	11663-122F7	31.29	8.77	1.38	1.09	1.45	0.36	0.58	1.30
Melanocyte - light, donor1	11274-116H5	2.82	1.88	0.24	0.00	0.00	0.00	0.24	0.24
Melanocyte - light, donor2	11351-117H1	3.41	1.36	0.00	0.68	0.68	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	6.07	0.87	0.00	0.00	0.00	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	20.41	4.27	1.15	2.29	3.02	1.87	1.67	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	18.56	2.96	1.08	5.11	2.15	2.15	2.69	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	15.00	5.62	1.61	1.07	0.80	0.27	0.27	1.07
Meningeal Cells, donor1	11493-119E8	17.74	2.23	1.74	2.36	1.36	0.50	1.12	1.12
Meningeal Cells, donor2	11573-120E7	13.20	3.96	0.88	1.32	0.88	1.32	1.76	0.88
Meningeal Cells, donor3	11654-122E7	48.82	9.78	3.26	4.16	1.63	1.63	1.87	1.87
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	41.63	9.70	2.85	3.71	1.43	1.71	1.71	1.43
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	25.16	5.13	2.01	2.82	1.51	0.91	1.71	0.91
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	1.31	2.62	0.00	2.62	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	33.73	7.18	1.44	2.87	2.87	1.44	1.44	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	19.27	5.08	2.75	0.85	1.48	0.85	0.64	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	18.60	4.02	2.01	1.51	3.02	0.50	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	10.77	3.08	1.32	1.76	0.88	0.44	0.66	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	10.23	2.92	0.73	2.19	0.73	1.46	2.19	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	9.82	1.02	0.00	1.23	1.64	1.43	0.61	0.82
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	22.30	3.46	3.88	1.94	3.05	0.28	0.97	1.25
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	4.09	1.12	1.12	0.74	0.00	0.00	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	28.55	4.74	1.45	1.71	1.71	0.26	0.26	2.76
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.34	0.89	0.89	0.00	0.00	0.59	0.00	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	6.40	0.00	0.00	3.20	0.00	0.00	0.64	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	42.53	10.99	2.84	3.90	1.42	3.19	1.77	2.13
Mesenchymal stem cells - hepatic, donor0	11218-116B3	22.20	4.38	2.19	2.50	1.56	0.31	0.00	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	23.95	3.63	2.18	2.18	2.18	0.00	3.63	0.73
Mesothelial Cells, donor1	11247-116E5	13.52	2.65	2.65	3.98	2.39	0.80	3.71	0.00
Mesothelial Cells, donor2	12156-128G5	12.01	1.50	1.00	3.00	2.50	1.50	3.00	0.00
Mesothelial Cells, donor3	11402-118D7	11.78	1.45	1.81	2.75	1.73	1.45	2.38	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	17.55	1.35	0.00	1.35	0.00	0.00	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	23.15	2.46	0.49	0.49	1.48	0.00	0.49	1.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	23.85	2.06	0.59	1.18	1.77	0.59	0.29	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	6.91	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	18.60	3.72	1.24	0.31	1.86	0.31	0.31	1.86
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	18.25	1.66	1.45	0.83	1.45	0.62	0.00	1.24
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	0.00	0.00	0.00	4.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	21.27	3.50	1.25	0.75	1.75	0.00	0.50	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	23.27	3.72	2.33	0.47	1.86	0.47	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	20.52	3.05	0.41	0.81	2.44	0.41	0.20	1.02
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	24.15	2.38	0.40	0.79	0.79	0.40	0.00	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	8.85	1.77	1.77	0.88	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	15.58	3.04	1.14	1.52	1.14	0.38	0.76	1.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	21.05	0.00	2.63	0.00	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	18.68	1.49	1.06	0.21	1.70	0.42	0.21	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	18.42	0.00	0.92	0.92	2.76	0.92	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	13.71	1.49	1.49	1.19	0.89	0.60	0.30	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	20.12	0.00	0.00	0.00	0.00	0.00	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	14.30	1.51	1.51	0.25	2.26	0.25	0.00	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	17.35	1.90	0.24	0.48	0.95	0.48	0.24	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	12.16	1.66	1.66	0.00	1.11	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	10.59	0.92	0.00	0.92	0.92	0.23	0.00	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	19.77	3.37	0.63	1.05	0.84	0.42	0.42	1.47
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	10.60	2.04	1.83	0.41	0.20	0.20	0.20	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	12.87	2.57	0.43	0.21	0.86	0.21	0.43	1.72
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	18.01	0.89	1.11	1.11	1.33	0.22	0.89	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	0.00	0.00	0.00	0.00	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	9.86	1.31	1.10	0.88	1.31	0.22	0.22	1.31
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	17.24	1.01	1.01	1.01	0.51	0.00	1.01	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	1.66	0.00	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	10.33	1.36	0.54	0.27	1.09	0.54	0.27	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	17.64	1.18	1.76	1.47	1.47	0.00	0.29	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	10.90	2.18	6.54	1.09	0.00	0.00	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	13.46	1.44	0.48	0.48	0.96	0.00	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	15.61	1.20	2.00	0.80	2.40	1.20	0.80	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	20.57	0.00	2.74	2.74	4.11	0.00	1.37	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	15.02	3.50	1.00	1.00	1.00	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	4.08	0.00	2.04	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	10.51	3.94	1.31	3.50	0.44	0.44	0.88	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	13.24	0.00	1.10	1.10	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	12.81	0.00	0.64	2.56	1.28	1.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	14.38	1.98	1.49	1.49	1.49	0.74	0.99	1.49
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	18.09	2.09	3.48	0.00	2.09	0.00	1.39	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	11.97	2.74	2.05	1.03	0.34	0.68	0.68	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	17.94	0.88	1.75	0.44	1.75	0.44	0.88	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	17.04	1.42	1.07	2.84	0.36	1.42	0.71	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	16.83	3.09	0.56	2.24	1.40	2.24	1.12	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	20.78	0.42	2.08	0.83	0.83	2.08	0.83	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	16.32	1.17	1.17	1.17	2.33	1.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	11.76	2.11	0.60	2.41	1.21	0.30	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	14.61	1.25	2.50	0.42	1.25	2.09	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	0.00	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	15.70	2.77	1.85	2.77	0.92	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	26.18	2.28	1.71	1.71	1.14	1.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	22.52	1.66	1.11	1.38	1.52	1.52	1.66	0.97
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	17.36	2.85	2.07	1.55	0.52	1.04	1.04	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	21.88	1.72	2.14	0.86	1.29	2.57	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	15.88	0.00	0.64	0.64	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	14.15	2.40	1.60	1.07	0.53	0.27	1.07	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	27.84	4.49	1.80	1.80	3.59	1.20	0.90	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	17.37	1.41	1.55	1.55	1.27	0.85	0.28	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	18.47	4.78	0.64	1.59	0.96	0.00	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	27.42	3.54	1.99	1.99	1.99	0.66	0.22	0.88
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	16.68	3.03	1.52	1.14	1.52	0.38	0.76	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	17.61	3.13	0.85	1.99	2.27	0.85	0.85	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	25.81	2.21	1.23	1.47	2.70	1.23	1.23	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	17.60	1.96	1.96	2.61	0.65	0.65	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	15.00	2.06	2.94	0.88	1.76	0.29	0.29	1.18
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	23.64	2.31	2.31	1.15	2.31	2.02	1.15	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	23.49	5.77	1.65	1.65	1.65	0.41	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	12.80	2.38	2.08	1.19	0.60	0.60	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	3.77	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	10.69	3.56	1.78	0.00	1.78	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	14.79	3.29	1.64	0.66	2.30	0.33	0.66	2.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	16.83	2.10	1.05	0.00	1.05	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	27.08	4.15	1.58	1.38	2.17	0.79	0.40	1.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	26.08	2.79	2.79	0.00	1.86	0.00	1.86	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	25.16	3.38	1.50	0.00	3.38	0.38	0.38	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	18.11	2.40	1.60	0.53	1.33	0.53	0.00	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	22.28	4.86	1.92	0.23	1.24	0.11	0.45	1.81
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	7.37	0.74	0.74	0.00	1.47	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	16.12	1.83	1.10	0.00	0.73	1.10	0.00	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	14.00	3.11	0.00	0.00	0.00	0.00	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	15.50	3.74	0.53	0.53	1.07	0.00	0.00	2.14
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	3.86	0.00	0.00	0.00	0.00	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	12.12	2.02	1.01	0.00	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	10.96	4.22	1.69	0.00	1.69	0.00	0.00	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	28.60	10.90	1.36	0.00	0.00	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	8.90	1.91	0.00	0.64	0.64	0.00	0.00	2.54
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	9.72	3.24	0.81	0.00	0.00	0.00	0.00	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	15.10	9.06	0.00	0.00	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	171.31	22.84	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	127.24	26.10	3.26	0.00	6.52	0.00	3.26	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	85.54	9.50	4.75	0.00	4.75	0.00	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	213.33	50.20	0.00	12.55	12.55	12.55	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	30.16	6.68	2.37	3.23	0.86	1.72	0.22	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	25.09	5.23	2.09	2.61	0.52	0.52	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	24.70	1.33	3.34	6.67	1.33	3.34	1.33	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	37.15	0.83	4.17	7.10	5.43	2.92	4.59	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	49.25	8.18	3.23	8.75	7.23	5.70	2.85	2.28
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	52.66	1.60	4.79	3.19	7.98	0.00	1.60	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	17.68	0.00	1.36	2.04	2.04	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	31.24	5.51	1.84	5.51	1.84	5.51	1.84	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	25.11	0.84	1.26	1.67	1.67	3.35	1.67	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	45.79	4.42	4.42	4.88	3.49	3.72	1.39	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	25.13	1.62	2.70	4.05	3.51	1.35	0.81	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	23.76	2.31	3.15	1.68	1.47	0.21	1.05	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	11.13	0.00	0.00	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	22.83	1.99	2.98	2.48	2.48	1.99	0.50	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	22.19	2.44	0.00	3.79	4.87	0.81	3.25	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	24.71	1.36	2.72	2.49	2.49	1.59	2.04	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	27.11	0.82	1.96	4.41	4.41	1.31	1.96	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	16.95	4.56	1.09	2.55	2.19	0.73	0.91	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	16.97	0.53	6.37	2.65	3.71	2.65	0.53	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	16.21	0.60	2.40	1.20	3.60	0.60	0.60	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	21.99	7.22	2.63	1.97	4.27	1.97	1.97	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	20.33	0.81	2.76	3.58	2.11	1.63	0.98	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	26.10	3.70	3.00	3.88	3.00	1.59	0.88	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	26.72	2.11	4.22	3.52	1.41	2.81	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	25.28	0.46	2.76	5.06	4.60	2.30	1.38	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	25.71	0.96	5.14	3.86	1.93	3.21	2.89	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	18.62	4.83	2.07	4.14	4.48	2.41	0.34	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	40.46	2.53	7.59	2.53	0.00	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	24.51	1.78	4.01	2.90	3.12	1.34	1.56	0.89
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	25.40	0.85	2.54	4.23	2.96	0.85	1.69	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	23.97	1.42	1.90	3.09	5.22	2.85	1.66	1.42
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	36.92	0.86	4.72	5.15	6.01	3.86	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	36.11	9.03	0.00	0.00	9.03	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	26.32	2.33	4.33	4.67	4.33	2.00	2.00	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	20.74	0.45	3.16	2.71	2.25	0.00	1.80	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	24.60	0.40	3.57	7.54	3.97	1.59	1.59	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	20.43	0.00	7.43	1.86	5.57	1.86	1.86	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	31.78	4.54	1.89	6.05	4.92	3.78	1.14	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	27.05	0.98	2.93	4.56	3.91	3.58	1.63	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	23.97	0.87	5.67	2.61	4.79	2.61	1.74	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	24.42	1.36	2.71	4.07	1.81	1.81	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	15.87	0.00	2.65	1.76	4.41	2.65	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	19.28	1.33	2.66	2.66	4.65	3.32	1.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	22.82	0.50	2.48	5.46	4.46	2.48	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	31.39	1.15	4.59	4.21	5.36	3.45	2.68	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	42.04	1.51	1.81	3.02	4.54	3.33	0.30	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	23.65	1.99	3.76	1.11	1.77	0.88	0.88	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	22.36	1.36	0.68	2.03	2.71	2.71	2.71	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	5.11	0.00	10.22	20.44	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	32.92	0.61	3.05	4.88	2.44	2.44	2.44	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	28.33	0.63	3.46	3.78	2.83	1.57	1.57	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	26.63	0.61	2.42	2.12	4.24	1.51	1.21	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	24.53	0.79	0.00	0.79	2.37	1.58	1.58	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	19.27	0.00	2.27	5.67	4.53	1.13	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	40.46	10.12	0.00	0.00	5.06	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	37.52	5.71	3.11	2.24	1.74	1.37	1.24	0.99
Myoblast, donor2	11322-117D8	35.67	5.56	1.73	4.03	2.30	1.92	1.15	0.77
Myoblast, donor3	11398-118D3	43.89	7.06	2.52	2.86	2.19	1.01	1.35	1.35
NK T cell leukemia cell line:KHYG-1	10777-110G3	40.86	4.09	0.73	1.31	1.17	0.29	0.29	1.90
Natural Killer Cells, donor1	11230-116C6	27.06	8.61	1.23	0.31	1.54	0.92	0.31	2.46
Natural Killer Cells, donor2	11311-117C6	17.19	9.35	0.60	1.51	0.90	0.00	0.00	1.81
Natural Killer Cells, donor3	11387-118C1	18.04	9.02	0.18	1.29	0.74	0.00	0.55	0.55
Neural stem cells, donor1	11275-116H6	54.44	14.15	3.27	1.81	1.09	0.73	0.36	1.81
Neural stem cells, donor2	11352-117H2	71.25	7.70	1.93	5.78	5.78	1.93	1.93	1.93
Neurons, donor1	11494-119E9	31.86	3.41	4.55	4.55	3.41	2.28	2.28	0.00
Neurons, donor2	11574-120E8	34.35	5.72	3.52	2.86	2.42	1.32	0.88	0.88
Neurons, donor3	11655-122E8	27.95	4.11	3.29	4.11	4.11	2.47	0.82	4.93
Neutrophils, donor1	11233-116C9	0.93	0.00	0.00	0.00	0.00	0.00	0.93	0.00
Neutrophils, donor2	11314-117C9	0.00	5.80	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	3.67	0.00	0.61	0.00	0.61	0.00	1.22	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	30.04	6.17	2.49	1.66	2.26	0.36	0.71	2.26
Nucleus Pulposus Cell, donor2	11409-118E5	25.07	3.91	1.30	2.93	1.30	0.65	0.33	1.63
Nucleus Pulposus Cell, donor3	11462-119B4	15.04	0.80	2.41	2.01	1.80	1.80	0.80	2.01
Olfactory epithelial cells, donor1	11933-125I7	18.58	4.82	0.83	1.51	1.10	0.28	0.55	0.83
Olfactory epithelial cells, donor2	11934-125I8	24.46	5.65	1.74	1.74	2.61	0.58	0.87	1.45
Olfactory epithelial cells, donor3	11935-125I9	21.00	4.77	2.38	1.36	2.16	0.34	0.45	1.14
Olfactory epithelial cells, donor4	11936-126A1	23.57	3.51	2.92	2.92	3.02	0.97	0.49	1.66
Oligodendrocyte - precursors, donor1	11496-119F2	33.70	3.01	1.20	0.60	2.41	1.81	1.20	2.41
Osteoblast - differentiated, donor1	11276-116H7	10.63	2.77	1.70	1.06	0.21	0.64	0.21	0.64
Osteoblast - differentiated, donor2	11353-117H3	8.00	1.14	4.57	3.43	1.14	1.14	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	19.24	3.72	0.62	1.86	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	10.55	3.13	0.98	1.37	0.20	0.39	0.20	0.39
Osteoblast, donor2	11354-117H4	25.28	9.13	3.51	4.21	2.11	0.00	1.40	0.70
Osteoblast, donor3	11426-118G4	16.71	3.20	1.07	6.40	1.07	2.13	0.53	0.71
Pancreatic stromal cells, donor1	11249-116E7	34.12	6.49	3.03	2.44	1.85	0.59	0.93	0.76
Pericytes, donor1	11491-119E6	4.23	0.22	0.11	0.33	0.11	0.00	0.00	0.45
Pericytes, donor2	11571-120E5	6.34	0.45	0.68	0.23	0.45	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	6.51	0.81	0.61	2.03	1.02	0.81	0.41	0.20
Perineurial Cells, donor1	11499-119F5	30.97	4.97	2.26	2.26	1.02	0.79	0.90	0.79
Perineurial Cells, donor2	11579-120F4	28.98	7.73	1.66	2.39	1.20	1.38	0.55	1.84
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	31.87	9.24	0.64	0.96	1.27	1.27	0.32	2.23
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	15.67	2.94	0.49	1.47	0.73	0.49	0.24	1.47
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	17.60	4.79	1.04	2.07	0.52	0.26	0.39	0.91
Placental Epithelial Cells, donor1	11278-116H9	19.13	2.63	1.20	0.72	0.72	0.48	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	5.54	5.54	1.11	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	8.83	2.75	0.39	0.59	0.59	0.20	0.20	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	11.08	3.80	1.27	1.27	1.90	0.32	0.32	0.63
Preadipocyte - breast, donor1	11467-119B9	19.88	4.69	1.88	1.31	0.38	0.56	0.75	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	27.02	5.09	2.48	1.44	2.09	0.65	0.78	0.39
Preadipocyte - breast, donor2	11328-117E5	22.29	4.05	1.35	1.80	1.58	0.45	0.68	1.13
Preadipocyte - omental, donor1	11468-119C1	20.89	4.37	3.20	1.39	0.96	0.53	0.43	0.32
Preadipocyte - omental, donor2	11329-117E6	23.13	3.49	5.24	0.87	1.31	0.44	0.00	2.18
Preadipocyte - omental, donor3	11403-118D8	22.49	5.16	2.58	1.00	0.43	0.72	0.29	1.00
Preadipocyte - perirenal, donor1	11469-119C2	11.81	1.97	1.97	1.97	0.00	0.00	0.98	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	10.75	1.84	0.61	0.92	0.61	0.61	0.00	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	53.83	9.03	3.01	6.37	3.90	1.42	2.30	2.12
Preadipocyte - subcutaneous, donor3	11428-118G6	37.29	7.15	3.58	2.55	1.87	1.19	1.53	1.87
Preadipocyte - visceral, donor1	11280-116I2	48.06	9.59	3.35	4.75	1.96	1.86	2.14	2.33
Preadipocyte - visceral, donor2	11357-117H7	34.05	6.44	4.14	6.44	1.84	0.92	1.38	1.38
Preadipocyte - visceral, donor3	11429-118G7	32.08	5.12	2.40	5.64	2.30	1.67	2.30	1.36
Prostate Epithelial Cells (polarized), donor1	11253-116F2	48.88	10.41	1.96	2.11	1.21	0.45	0.91	0.91
Prostate Epithelial Cells, donor2	11331-117E8	17.06	2.17	2.44	1.35	1.76	1.22	0.41	0.27
Prostate Epithelial Cells, donor3	11404-118D9	10.17	0.98	1.53	2.76	0.98	1.71	1.10	0.37
Prostate Stromal Cells, donor1	11254-116F3	28.48	6.49	2.62	3.87	0.91	2.05	2.05	0.80
Prostate Stromal Cells, donor2	11332-117E9	29.40	5.38	3.05	4.30	2.69	2.33	1.61	0.36
Prostate Stromal Cells, donor3	11405-118E1	15.02	3.02	2.40	1.88	1.67	0.42	0.73	0.83
Renal Cortical Epithelial Cells, donor1	11516-119H4	4.01	0.36	0.73	1.09	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	26.13	2.77	2.29	2.56	1.25	0.90	0.69	0.35
Renal Epithelial Cells, donor1	11517-119H5	4.57	0.00	1.01	0.51	0.00	1.01	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	5.69	0.00	0.00	0.00	0.00	0.00	0.71	0.71
Renal Epithelial Cells, donor3	11678-122H4	34.83	2.96	2.33	1.69	2.01	0.74	0.74	0.74
Renal Glomerular Endothelial Cells, donor1	11514-119H2	6.13	0.68	0.00	0.00	0.68	0.00	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	11.99	1.35	0.94	2.29	0.94	0.81	0.67	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	40.85	8.44	1.55	4.66	3.11	1.11	2.66	2.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	1.33	0.00	0.00	0.00	0.00	0.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	5.28	1.10	0.22	1.98	0.00	0.44	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	3.76	0.63	0.00	0.00	0.63	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	1.66	1.11	0.00	0.55	0.28	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	11.27	0.81	0.81	3.76	0.54	2.15	0.54	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	2.53	1.69	0.42	2.53	0.00	0.42	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	8.29	0.77	0.96	2.12	0.58	0.19	0.58	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	29.04	3.37	1.81	3.11	0.52	2.07	0.26	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	7.39	0.85	1.14	1.71	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	1.03	1.03	1.03	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	20.83	1.25	1.25	0.50	0.00	0.50	0.75	1.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	66.55	13.76	2.00	1.20	1.20	0.53	0.67	1.07
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	25.02	2.68	2.68	0.00	0.89	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	36.32	6.60	3.85	0.00	3.30	1.10	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	30.16	8.70	1.16	0.58	4.64	0.58	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	40.57	5.98	3.51	2.08	3.12	0.26	0.65	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	33.17	4.67	1.49	1.19	1.99	0.60	0.50	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	47.07	5.80	3.57	1.45	1.34	0.45	0.22	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	58.18	6.08	3.10	2.11	3.23	1.12	0.37	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	38.23	4.89	2.45	1.28	1.52	0.47	0.70	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	51.77	5.55	3.24	2.77	4.39	0.46	0.92	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	36.01	3.70	3.01	2.19	3.70	1.10	1.10	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	43.42	3.78	2.42	1.21	2.27	1.06	0.30	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	43.01	4.84	3.05	1.79	1.43	0.72	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	36.58	4.45	3.01	0.43	2.44	1.29	0.57	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	35.52	3.22	2.68	1.61	1.72	1.29	0.75	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	45.14	4.87	1.55	3.54	1.33	1.99	0.66	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	24.85	4.21	4.40	2.29	2.29	1.15	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	39.41	4.29	2.70	1.12	2.61	0.56	0.65	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	50.36	8.08	4.70	1.50	1.69	0.38	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	35.70	3.98	2.52	2.65	4.25	1.86	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	41.37	4.38	2.53	2.34	3.31	1.56	0.49	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	41.63	5.54	3.06	3.25	1.15	0.57	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	37.91	4.16	2.56	1.60	2.24	2.03	0.64	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	38.12	2.52	2.24	1.40	1.68	0.28	0.28	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	41.19	4.96	2.73	1.88	2.56	1.03	1.37	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	35.55	3.46	4.56	1.28	2.37	1.28	0.18	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	32.74	4.17	2.21	2.45	1.35	0.98	0.12	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	39.22	5.78	1.61	2.42	1.48	0.67	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	33.02	5.66	4.48	1.65	3.30	1.42	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	30.75	3.37	2.38	1.39	2.38	1.19	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	44.43	5.85	2.81	1.64	2.10	0.47	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	32.55	3.94	6.84	3.11	2.70	1.45	0.21	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	33.85	7.08	2.43	0.88	2.21	0.44	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	38.43	4.39	3.34	1.04	1.88	0.84	1.25	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	35.13	3.90	4.98	2.96	3.63	0.40	0.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	41.21	3.58	2.04	2.21	2.72	0.85	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	40.29	5.40	2.89	2.70	3.08	0.77	0.39	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	33.18	6.53	4.30	1.72	3.27	1.55	0.52	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	34.43	5.90	2.47	1.51	4.39	0.82	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	52.21	7.72	4.60	2.63	4.93	1.48	0.82	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	29.65	4.94	4.09	1.70	2.73	1.19	0.85	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	26.93	5.18	2.52	1.78	2.52	1.04	0.44	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	44.25	6.13	4.00	2.93	2.67	0.80	0.53	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	29.87	2.63	3.04	1.52	1.52	0.55	0.14	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	35.72	3.33	2.38	1.67	2.38	1.43	0.48	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	49.18	2.42	2.22	0.81	1.01	1.01	0.40	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	27.88	3.39	1.79	1.51	1.98	0.94	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	49.26	4.54	2.10	0.70	2.45	0.70	0.00	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	28.41	4.84	1.21	1.21	2.72	0.30	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	32.68	3.92	2.08	1.10	2.57	0.49	0.12	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	86.17	11.79	3.06	1.75	3.78	0.73	0.44	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	35.90	8.52	0.61	0.00	3.04	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	28.03	4.82	1.81	0.30	1.81	0.90	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	33.02	5.43	1.13	1.13	1.81	0.00	0.23	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	36.24	4.79	3.00	0.90	2.10	0.60	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	28.69	4.96	2.36	0.35	1.77	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	24.76	3.20	2.35	0.43	1.49	0.21	0.00	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	28.25	6.01	2.40	0.00	4.21	0.60	0.00	0.60
Schwann Cells, donor1	11498-119F4	6.77	0.94	0.56	0.19	0.38	0.56	0.19	0.19
Schwann Cells, donor2	11578-120F3	17.01	0.00	6.80	0.00	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	21.69	5.04	1.75	2.85	0.44	1.10	0.66	0.66
Sebocyte, donor1	11220-116B5	10.96	3.29	0.55	1.64	1.10	0.55	0.00	1.10
Sebocyte, donor2	11301-117B5	13.33	2.76	1.84	1.38	1.38	0.46	0.00	0.00
Sebocyte, donor3	11378-118B1	6.18	1.44	0.41	0.62	0.41	0.41	0.21	0.00
Sertoli Cells, donor1	11255-116F4	21.54	4.97	0.00	3.31	1.66	0.00	1.66	4.97
Sertoli Cells, donor2	11333-117F1	16.95	5.65	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	25.95	4.57	1.85	2.02	1.58	0.88	0.62	0.97
Skeletal Muscle Cells, donor2	11358-117H8	5.78	1.45	0.72	0.00	0.00	0.00	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	13.38	1.67	0.84	5.02	3.34	0.84	2.51	2.51
Skeletal Muscle Cells, donor4	11451-119A2	35.97	4.08	3.46	5.97	1.10	2.20	1.89	1.10
Skeletal Muscle Cells, donor5	11455-119A6	34.04	4.61	1.34	4.76	3.42	2.97	1.34	2.53
Skeletal Muscle Cells, donor6	11459-119B1	41.40	4.62	3.23	7.54	2.77	3.08	2.62	0.92
Skeletal Muscle Satellite Cells, donor1	11240-116D7	43.09	7.69	2.65	1.51	2.39	0.88	0.76	3.53
Skeletal Muscle Satellite Cells, donor2	11321-117D7	30.96	5.71	1.00	1.57	2.43	0.71	1.00	2.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	44.64	6.45	3.37	5.36	1.98	2.48	1.69	1.09
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	25.95	4.38	2.95	2.53	0.67	0.84	0.84	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	13.03	2.90	0.00	1.45	0.72	0.72	1.45	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	7.98	1.93	1.10	1.79	0.96	0.28	0.14	0.55
Skin - palm, donor1	10286-104F7	42.98	8.06	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	8.65	1.01	1.59	1.59	1.15	0.86	0.43	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	19.63	13.90	13.90	6.54	4.91	0.82	1.64	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	8.18	4.15	1.43	1.04	1.69	1.56	0.26	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	27.11	6.81	1.67	2.78	1.95	0.56	0.97	1.11
Small Airway Epithelial Cells, donor2	11334-117F2	19.55	5.49	0.56	1.13	1.41	0.84	0.56	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	47.36	13.74	2.75	3.38	1.90	2.11	1.69	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	15.51	2.47	1.42	1.95	0.90	0.45	0.67	0.90
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	15.74	5.86	4.94	4.01	2.16	3.09	1.85	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	20.01	3.11	4.00	2.22	1.33	2.45	1.11	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	12.93	4.11	2.94	2.94	0.00	1.18	1.76	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	7.96	1.77	1.33	1.10	1.77	0.22	1.10	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	11.42	2.76	1.58	1.97	0.00	0.00	1.18	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	13.13	0.77	2.32	3.86	0.77	0.77	1.55	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	27.02	5.00	0.00	2.00	0.00	1.00	1.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	16.50	3.86	1.60	1.60	0.53	0.80	0.93	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	29.92	10.42	1.77	3.77	1.55	1.55	1.11	2.88
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	27.40	4.35	2.43	5.25	2.30	1.79	2.05	1.41
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	31.58	5.86	2.28	3.26	2.93	1.30	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	25.69	4.43	2.95	2.66	0.59	0.89	1.48	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	17.23	1.99	2.70	4.27	1.42	1.99	2.28	1.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	5.04	0.33	0.49	1.63	0.00	0.00	0.49	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	16.44	1.52	2.13	1.52	0.00	0.91	0.61	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	9.85	2.02	0.51	1.52	1.01	0.76	0.25	1.52
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	10.49	1.43	0.95	4.29	0.48	0.00	0.00	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	22.42	4.13	2.51	3.39	1.47	0.74	1.77	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	24.75	2.15	0.65	2.58	1.08	1.94	1.08	1.29
Smooth Muscle Cells - Colonic, donor3	11396-118D1	28.23	4.20	1.15	3.57	1.99	1.36	1.47	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	12.37	1.08	1.55	2.47	0.31	0.93	0.77	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	15.09	0.00	2.16	3.23	0.00	1.08	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	15.84	1.49	0.90	5.08	3.29	1.79	2.09	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.41	0.34	0.34	1.71	0.00	0.00	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	39.66	8.25	1.49	1.88	1.96	0.24	0.71	2.20
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	20.83	2.21	5.33	3.82	2.42	2.42	2.01	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	24.80	5.92	3.19	7.51	2.73	2.05	3.19	1.37
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	6.04	1.81	1.21	3.02	0.60	1.81	0.60	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	56.69	12.19	3.44	7.68	2.12	2.38	2.91	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	34.89	6.13	1.33	3.20	1.86	0.27	1.33	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	25.80	4.76	2.25	3.88	2.13	0.88	1.75	1.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	17.00	4.31	1.01	0.51	1.27	0.25	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	22.92	5.43	3.17	2.41	1.06	0.90	1.21	1.66
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	6.75	3.00	0.75	0.75	0.75	0.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	3.88	0.00	2.58	3.88	18.09	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	13.02	3.72	1.40	1.86	1.40	0.00	1.40	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	13.63	3.03	1.01	3.53	1.51	1.01	0.50	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	10.03	0.94	0.63	3.13	0.63	1.25	0.63	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	4.13	0.29	0.29	0.59	0.29	0.29	0.29	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	45.40	9.41	3.25	6.41	1.67	3.33	2.50	2.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	20.56	4.20	2.80	1.40	1.40	0.93	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	14.68	1.58	1.30	2.59	0.58	0.29	1.58	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	17.85	3.57	0.76	2.29	0.25	1.02	2.04	1.78
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	12.22	1.50	1.13	1.50	0.56	1.50	1.13	1.13
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	36.89	4.33	3.21	3.63	1.96	1.68	1.96	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	25.56	3.69	2.93	3.27	1.76	1.51	0.92	1.01
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	0.95	0.00	0.95	0.00	0.95	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	13.21	1.71	1.47	3.91	0.73	1.22	0.98	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	24.75	3.98	4.20	3.98	1.99	1.77	2.21	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	31.60	5.27	0.29	1.17	0.88	1.46	0.88	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	14.19	1.75	2.33	2.72	1.75	0.58	0.39	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	13.75	2.91	1.85	2.12	1.32	1.85	0.53	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	21.20	5.95	5.58	1.12	1.12	1.86	1.12	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	15.81	1.80	3.95	3.23	1.44	1.08	2.52	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	17.03	2.56	2.84	5.11	1.42	1.99	1.99	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	20.09	7.09	4.33	5.12	3.15	3.15	1.97	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	15.74	2.03	3.05	2.79	1.52	1.52	0.76	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	13.58	3.59	3.99	2.40	0.00	1.20	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	12.96	2.93	4.60	2.93	1.25	0.84	0.84	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	18.33	5.04	1.83	0.92	1.38	0.92	1.38	0.92
Synoviocyte, donor1	11291-117A4	29.79	8.25	3.03	1.85	2.36	0.67	0.34	0.84
Synoviocyte, donor2	11368-117I9	15.25	8.05	1.01	1.34	2.35	0.67	0.34	1.84
Synoviocyte, donor3	11440-118H9	14.75	2.68	1.34	1.56	1.34	0.22	0.45	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	13.58	0.71	0.36	1.07	0.36	1.79	0.00	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	0.00	0.00	0.00	1.98	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	5.33	0.69	0.23	0.69	0.00	0.93	0.00	0.93
Tracheal Epithelial Cells, donor1	11292-117A5	11.33	3.23	0.72	1.15	0.36	0.29	0.29	1.36
Tracheal Epithelial Cells, donor2	11369-118A1	7.73	0.77	0.00	0.00	0.00	0.77	0.77	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	3.44	0.57	0.57	0.00	0.57	0.00	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	67.42	13.90	2.34	1.85	1.48	0.25	0.86	0.86
Urethra, donor2	10319-105A4	46.76	7.19	7.19	0.00	3.60	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	3.19	0.00	0.27	0.27	0.27	0.27	0.53	0.00
Urothelial Cells, donor2	11600-120H7	2.40	0.00	0.80	0.00	0.40	0.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	3.90	0.23	0.23	0.46	0.46	0.00	0.46	0.00
Urothelial cells, donor0	11216-116B1	22.51	1.11	2.01	0.67	1.11	0.22	0.67	1.56
Whole blood (ribopure), donor090309, donation1	12179-129A1	30.25	8.90	0.89	0.89	1.78	0.00	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	18.58	4.29	2.86	4.29	1.43	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	17.11	3.42	0.68	1.37	0.68	1.37	0.68	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	28.92	7.92	0.69	1.38	1.03	0.69	0.69	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	29.05	5.23	0.58	0.58	0.58	1.74	0.00	2.91
Whole blood (ribopure), donor090612, donation1	12182-129A4	17.70	1.04	4.16	3.12	4.16	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	19.27	10.10	2.75	2.75	1.84	1.84	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	18.26	1.83	1.83	0.00	0.91	0.00	0.91	1.83
Wilms' tumor cell line:G-401	10809-111A8	45.64	9.38	0.86	1.23	1.85	1.11	0.37	1.48
Wilms' tumor cell line:HFWT	10597-108E3	40.48	2.64	1.76	2.64	2.64	0.88	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	33.80	5.59	1.40	5.31	0.56	3.35	1.40	0.00
achilles tendon, donor2	10292-104G4	20.67	0.00	2.07	0.00	4.13	0.00	0.00	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	33.91	6.37	0.76	1.53	1.02	0.00	0.25	2.55
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	64.08	15.32	1.86	2.32	1.86	0.46	0.23	1.16
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	59.95	7.24	1.19	1.54	0.95	0.47	0.24	1.42
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	81.91	10.88	2.45	6.26	3.54	3.54	2.45	2.18
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	60.71	7.59	3.37	1.69	1.12	0.84	0.00	3.65
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	43.78	9.09	0.21	0.63	0.85	0.42	0.21	2.33
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	30.76	8.17	0.54	1.09	0.54	0.27	0.82	5.99
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	50.67	9.69	0.88	1.32	1.32	0.00	0.88	4.41
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	68.60	6.94	1.23	0.82	2.04	0.00	0.00	4.08
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	54.36	9.32	0.78	0.78	1.55	0.00	0.00	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	51.89	14.35	2.02	1.84	1.66	0.92	0.74	3.50
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	54.61	11.70	3.90	0.00	3.90	3.90	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	49.50	12.32	1.86	1.39	1.63	0.46	0.46	4.18
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	49.45	10.10	1.81	2.33	3.11	1.04	0.00	1.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	34.48	6.43	2.92	1.17	3.21	0.00	0.29	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	30.21	6.51	1.39	1.86	1.86	0.46	0.93	1.86
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	47.71	17.27	2.47	2.88	3.29	0.41	0.82	2.88
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	35.61	2.15	2.46	0.92	3.07	0.92	0.00	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	43.52	10.67	0.85	0.85	0.00	0.43	0.00	2.56
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	45.49	8.49	1.21	1.82	2.12	0.61	0.30	2.12
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	45.97	8.42	2.41	1.20	2.65	1.93	0.24	1.93
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	48.33	9.58	1.11	3.12	1.11	0.22	0.00	2.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	43.36	5.34	3.67	4.34	2.33	2.33	1.67	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	59.46	7.43	3.72	0.00	1.86	0.00	1.86	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	31.26	9.79	1.51	0.75	0.38	0.75	0.38	3.01
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	32.71	9.16	0.44	0.87	2.18	0.87	0.00	1.74
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	16.87	13.12	0.00	0.00	0.00	0.00	0.00	7.50
adenocarcinoma cell line:IM95m	10796-110I4	24.49	3.30	0.47	2.35	1.41	0.71	0.94	0.71
adipose tissue, adult, pool1	10010-101C1	33.82	6.98	2.17	0.93	2.33	0.16	0.47	1.40
adipose, donor1	10184-103D4	95.00	14.66	2.93	5.28	8.21	3.52	0.59	2.93
adipose, donor2	10185-103D5	36.50	2.03	1.62	1.62	2.43	1.22	0.00	1.22
adipose, donor3	10186-103D6	37.30	4.63	1.91	2.72	3.81	2.45	2.45	1.09
adipose, donor4	10187-103D7	42.47	7.80	3.47	6.07	2.60	4.33	2.60	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	42.14	3.00	4.10	2.37	1.89	1.89	0.95	0.47
adrenal gland, adult, pool1	10081-102A9	21.83	3.64	0.00	3.64	3.64	0.00	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	18.41	3.20	0.67	0.67	0.27	0.27	0.00	1.33
alveolar cell carcinoma cell line:SW 1573	10708-109H6	60.03	9.29	0.36	1.07	1.79	1.79	0.71	1.79
amniotic membrane cells, donor1	12235-129G3	40.11	9.27	1.62	1.39	2.32	0.23	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	35.84	7.10	6.09	0.34	2.37	0.00	0.00	1.01
amniotic membrane cells, donor3	12237-129G5	37.12	5.60	6.78	1.18	7.07	1.18	0.29	0.59
amygdala - adult, donor10196	10167-103B5	49.80	18.97	5.93	0.00	9.49	2.37	0.00	0.00
amygdala, adult, donor10252	10151-102I7	106.45	25.55	3.45	1.01	8.11	0.20	0.20	1.42
amygdala, newborn, donor10223	10360-105E9	47.12	16.14	2.90	0.97	4.84	1.61	1.61	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	33.11	3.82	1.15	2.16	0.64	0.25	0.25	1.40
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	46.99	4.85	3.53	9.93	1.32	2.21	1.76	3.09
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	71.48	6.01	4.01	4.01	2.34	1.34	1.00	2.34
aorta, adult, pool1	10052-101G7	27.07	4.51	1.77	0.78	4.12	0.59	0.39	1.18
appendix, adult	10189-103D9	41.53	4.66	3.49	1.55	5.05	0.00	0.78	2.72
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	84.61	24.42	2.75	1.38	4.13	0.34	0.34	3.78
artery, adult	10190-103E1	28.53	13.59	4.08	1.36	4.08	0.00	0.00	4.08
astrocytoma cell line:TM-31	10425-106D2	36.07	5.50	2.46	0.72	1.45	0.43	0.00	1.01
b cell line:RPMI1788	10427-106D4	48.63	7.29	1.04	2.83	0.89	0.30	0.00	4.91
basal cell carcinoma cell line:TE 354.T	10702-109G9	21.36	3.33	2.77	3.61	1.94	0.28	0.83	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	24.71	3.57	1.49	1.19	0.79	0.10	0.30	1.69
bile duct carcinoma cell line:TFK-1	10496-107C1	10.04	1.67	0.33	1.17	0.50	0.33	0.33	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	40.27	2.80	1.12	0.56	1.12	0.00	0.56	2.80
bladder, adult, pool1	10011-101C2	35.09	4.89	2.50	1.63	1.52	0.11	0.54	1.20
blood, adult, pool1	10053-101G8	6.64	6.64	2.21	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	22.27	11.13	2.57	0.86	0.86	0.86	0.00	1.71
bone marrow, adult	10192-103E3	26.32	6.07	3.37	0.67	4.72	0.67	0.67	3.37
brain, adult, donor1	10084-102B3	41.00	7.18	1.03	0.00	4.10	0.00	0.00	2.05
brain, adult, pool1	10012-101C3	54.12	19.82	2.23	1.45	4.12	0.56	0.00	1.00
brain, fetal, pool1	10085-102B4	40.07	0.00	0.00	0.00	5.34	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	43.28	5.62	3.30	0.33	2.97	1.32	0.33	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	36.57	15.73	3.37	1.87	2.00	0.50	0.25	1.00
breast, adult, donor1	10080-102A8	44.83	3.79	3.16	2.53	2.53	0.00	1.89	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	30.36	14.74	3.56	1.02	1.14	2.29	0.38	2.03
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	30.61	9.59	3.40	0.93	0.93	0.93	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	30.85	8.52	1.84	2.07	1.38	1.84	0.69	1.15
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	15.01	4.60	0.73	1.69	1.69	0.24	0.24	0.48
carcinoid cell line:NCI-H1770	10703-109H1	45.14	3.29	6.58	8.93	4.23	4.23	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	27.13	3.50	1.86	1.09	2.84	0.55	0.33	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	61.48	7.61	0.95	1.58	2.22	1.58	0.63	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	44.72	8.25	4.26	7.72	2.93	0.80	3.19	2.66
caudate nucleus - adult, donor10196	10177-103C6	78.29	27.63	5.76	1.15	8.06	2.30	1.15	1.15
caudate nucleus, adult, donor10252	10164-103B2	103.07	28.11	2.34	1.34	6.19	0.50	0.67	1.00
caudate nucleus, adult, donor10258	10379-105H1	52.73	24.45	0.76	0.00	3.82	0.00	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	69.58	18.31	5.13	3.66	3.66	0.00	1.10	2.20
cerebellum - adult, donor10196	10173-103C2	104.88	26.22	20.39	2.91	17.48	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	143.69	32.03	5.98	1.71	10.46	0.64	0.21	1.28
cerebellum, adult, pool1	10083-102B2	44.50	6.55	0.69	0.00	8.28	0.69	0.34	2.76
cerebellum, newborn, donor10223	10357-105E6	119.56	16.61	9.13	1.66	16.61	1.66	0.83	1.66
cerebral meninges, adult	10188-103D8	65.05	17.65	2.27	1.26	4.29	0.50	0.25	1.51
cerebrospinal fluid, donor2	10294-104G6	40.93	5.12	2.19	1.46	2.19	0.00	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	37.96	4.46	1.01	0.58	0.29	0.14	0.14	1.73
cervical cancer cell line:ME-180	10553-107I4	37.29	5.97	0.99	1.16	0.66	0.17	0.17	0.50
cervix, adult, pool1	10013-101C4	35.38	10.92	3.67	1.68	3.04	0.73	1.57	0.73
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	26.20	5.85	1.39	1.95	1.25	0.14	0.84	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	24.82	2.61	1.31	3.92	2.61	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	51.20	10.69	1.99	1.49	2.11	0.99	0.25	0.50
choriocarcinoma cell line:SCH	10785-110H2	57.42	9.61	1.97	0.49	1.85	0.74	0.25	2.34
choriocarcinoma cell line:T3M-3	10618-108G6	28.46	4.03	1.90	0.47	0.95	0.47	0.24	0.95
chorionic membrane cells, donor1	12238-129G6	33.62	8.55	2.85	0.28	1.71	0.28	0.28	0.28
chorionic membrane cells, donor2	12239-129G7	35.20	7.95	2.78	1.99	1.79	0.89	0.89	0.99
chorionic membrane cells, donor3	12240-129G8	35.17	8.79	2.20	0.55	1.65	0.55	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	19.19	5.05	2.02	1.01	2.02	0.00	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	49.37	12.29	1.15	0.96	1.73	1.54	0.58	1.34
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	68.21	20.27	2.11	0.00	4.01	0.63	0.21	4.43
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	31.59	5.91	2.82	2.31	2.05	0.51	0.26	1.54
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	38.22	8.71	2.42	1.45	2.18	1.45	1.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	37.46	11.40	1.63	2.24	1.02	1.83	0.61	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	55.65	15.31	3.83	4.42	1.77	0.59	0.00	2.06
chronic myelogenous leukemia cell line:KU812	10409-106B4	69.33	28.93	1.04	1.04	2.35	0.52	0.00	5.21
clear cell carcinoma cell line:JHOC-5	10638-108I8	34.74	5.94	1.83	2.06	2.51	0.91	0.23	0.00
clear cell carcinoma cell line:TEN	10636-108I6	24.46	4.16	1.39	1.21	1.04	0.69	0.17	0.35
colon carcinoma cell line:CACO-2	10513-107D9	68.46	9.70	3.48	4.21	2.01	1.83	2.56	1.28
colon carcinoma cell line:COLO-320	10420-106C6	98.44	26.23	2.66	0.00	0.76	1.14	0.00	6.08
colon, adult, donor1	10082-102B1	24.99	5.95	7.14	1.19	2.38	1.19	2.38	1.19
colon, adult, pool1	10014-101C5	31.49	8.81	3.29	3.06	2.23	0.71	1.53	0.59
colon, fetal, donor1	10070-101I7	32.14	8.03	0.62	1.85	4.33	0.62	1.24	0.00
common myeloid progenitor CMP, donor1	12130-128D6	73.34	13.75	0.00	4.58	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	71.81	15.72	1.27	4.25	1.70	1.27	3.82	8.50
cord blood derived cell line:COBL-a 24h infection	10453-106G3	49.20	10.26	1.21	3.77	0.91	0.75	1.21	3.47
cord blood derived cell line:COBL-a untreated	10449-106F8	58.38	11.42	2.12	3.38	1.13	0.85	0.99	4.65
corpus callosum, adult, pool1	10042-101F6	64.68	14.48	4.42	1.00	3.87	0.33	0.33	1.00
cruciate ligament, donor2	10295-104G7	35.66	3.24	3.24	1.62	2.43	0.81	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	36.92	4.82	5.62	1.61	5.62	1.61	0.00	0.00
diencephalon, adult	10193-103E4	42.72	16.32	2.64	1.68	4.32	0.00	0.24	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	41.56	13.32	2.07	1.38	1.15	0.23	0.00	3.90
ductal cell carcinoma cell line:KLM-1	10438-106E6	32.31	5.90	2.05	0.77	3.33	0.26	0.26	1.28
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	35.15	4.09	0.48	2.89	0.96	1.20	0.72	4.09
ductus deferens, adult	10196-103E7	29.40	1.99	4.98	0.50	4.98	0.50	0.50	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	28.80	4.32	1.44	1.44	5.76	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	27.22	11.03	4.41	0.00	3.68	0.00	0.74	1.47
dura mater, adult, donor1	10041-101F5	23.29	13.13	1.40	0.83	0.99	0.17	0.50	2.31
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	25.76	3.11	0.44	1.11	0.00	0.22	0.00	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	31.24	3.30	1.86	2.29	0.72	0.86	0.86	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	60.43	6.78	1.85	4.32	5.55	1.23	0.00	4.93
embryonic pancreas cell line:1C3D3	10605-108F2	47.22	10.29	3.63	2.72	3.03	0.61	0.30	3.63
embryonic pancreas cell line:1C3IKEI	10606-108F3	65.15	9.88	1.85	2.47	4.01	1.54	1.23	4.32
embryonic pancreas cell line:2C6	10603-108E9	63.05	11.82	2.63	2.63	5.25	0.00	0.00	6.57
endometrial carcinoma cell line:OMC-2	10497-107C2	16.76	3.02	0.34	1.34	0.67	0.67	0.67	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	68.87	14.68	4.17	5.62	2.90	1.81	2.90	2.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	28.46	2.25	2.89	3.22	1.93	0.80	1.45	0.16
epidermoid carcinoma cell line:A431	10426-106D3	22.12	8.11	0.89	2.67	0.56	0.56	0.44	0.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	24.75	4.07	1.32	2.97	0.44	0.77	0.99	0.11
epididymis, adult	10197-103E8	25.54	7.54	2.51	0.42	2.93	0.42	0.00	1.88
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	16.14	2.66	0.71	0.89	0.89	0.00	0.18	0.89
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	17.70	2.75	0.00	1.57	1.57	0.79	0.39	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	53.34	9.04	1.31	1.44	0.52	0.66	0.52	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	53.05	10.43	1.18	1.28	0.59	0.30	0.10	0.89
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	47.05	11.76	1.57	2.13	1.12	0.22	0.56	1.12
esophagus, adult, pool1	10015-101C6	24.74	6.58	2.23	2.34	1.70	0.53	0.96	0.85
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	33.31	7.01	1.63	0.50	1.63	0.13	0.25	2.13
eye - muscle inferior rectus, donor1	10272-104E2	50.71	14.49	7.24	0.00	9.66	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	35.77	0.00	0.00	0.00	0.00	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	53.58	5.95	2.98	1.49	2.98	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	36.69	3.44	6.88	2.29	5.73	0.00	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	29.15	2.91	1.46	1.46	1.46	0.00	0.00	2.91
eye, fetal, donor1	10054-101G9	31.02	7.88	3.31	1.02	5.08	1.02	0.51	2.03
fibrosarcoma cell line:HT-1080	10758-110E2	28.59	5.26	1.03	2.05	1.28	1.15	0.51	3.08
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	57.46	7.36	3.09	3.09	4.04	1.90	0.71	2.37
frontal lobe, adult, pool1	10040-101F4	82.85	23.27	2.81	0.38	4.88	0.38	0.09	1.22
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	53.74	20.12	3.90	2.70	3.30	1.20	0.90	2.70
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	34.47	4.21	3.47	1.92	1.37	0.82	0.27	0.46
gall bladder, adult	10198-103E9	22.45	3.38	1.93	0.72	2.41	0.72	0.24	0.48
gamma delta positive T cells, donor1	11937-126A2	24.16	10.20	2.15	0.54	3.22	0.00	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	30.25	12.70	4.11	1.49	1.12	0.37	0.75	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	28.94	7.18	1.90	1.27	2.11	0.21	0.21	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	35.01	6.58	3.29	0.77	2.90	0.58	0.39	0.77
gastric cancer cell line:AZ521	10549-107H9	42.46	3.44	2.46	2.79	1.48	0.49	0.49	1.64
gastric cancer cell line:GSS	10560-108A2	44.85	7.32	2.75	2.75	1.83	0.00	0.92	2.75
gastrointestinal carcinoma cell line:ECC12	10615-108G3	28.10	2.97	0.91	0.46	1.14	0.23	0.00	0.69
giant cell carcinoma cell line:LU65	10487-107B1	23.52	3.33	2.07	0.23	1.49	0.57	0.23	1.15
giant cell carcinoma cell line:Lu99B	10433-106E1	39.61	5.74	1.96	0.28	0.84	0.28	0.00	2.24
glassy cell carcinoma cell line:HOKUG	10688-109F4	28.68	7.73	1.25	2.49	0.75	0.00	0.75	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	25.44	3.80	0.84	1.37	0.95	0.21	0.42	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	24.30	5.06	1.26	0.98	1.40	0.56	0.28	1.40
glioblastoma cell line:T98G	10485-107A8	34.11	6.07	0.66	1.10	0.55	0.33	0.22	2.21
glioma cell line:GI-1	10413-106B8	65.60	12.89	2.64	2.64	1.76	0.59	1.46	2.34
globus pallidus - adult, donor10196	10175-103C4	61.23	12.39	4.37	0.00	10.20	1.46	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	137.67	20.02	4.64	0.73	5.86	1.22	0.49	0.49
globus pallidus, adult, donor10258	10367-105F7	72.57	12.32	4.11	0.00	6.85	1.37	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	39.44	6.93	1.07	1.60	4.26	2.13	2.13	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	46.50	4.89	2.45	4.89	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	10.93	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	0.00	0.00	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	25.60	7.04	1.92	0.96	4.48	0.64	0.64	0.64
hIPS +CCl2, biol_rep1	14383-156B9	21.12	13.77	5.05	5.05	2.75	5.05	0.92	0.92
hIPS +CCl2, biol_rep2	14384-156C1	16.46	16.00	5.94	4.12	2.29	2.74	0.91	1.37
hIPS +CCl2, biol_rep3	14385-156C2	16.75	7.73	7.09	6.44	2.58	1.29	1.29	0.00
hIPS, biol_rep1	14380-156B6	18.68	21.56	8.62	1.44	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	17.15	13.03	7.54	3.43	2.74	2.06	0.69	0.69
hIPS, biol_rep3	14382-156B8	24.28	14.35	2.21	4.41	5.52	3.31	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	37.64	3.45	1.72	2.30	1.15	0.00	0.86	1.72
heart - mitral valve, adult	10205-103F7	50.23	11.66	1.49	2.09	6.58	0.90	0.00	2.09
heart - pulmonic valve, adult	10206-103F8	39.48	10.46	4.18	1.05	7.32	0.52	0.52	1.31
heart - tricuspid valve, adult	10207-103F9	65.78	10.82	2.50	0.83	4.16	0.83	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	23.06	4.69	3.26	0.41	4.29	0.82	0.61	0.41
heart, adult, diseased, donor1	10051-101G6	17.88	2.55	1.28	1.28	1.70	0.00	0.43	0.43
heart, adult, pool1	10016-101C7	34.04	7.59	1.61	2.07	1.38	0.92	0.23	0.23
heart, fetal, pool1	10046-101G1	70.95	14.89	3.29	0.41	2.57	0.41	0.72	1.64
hepatic mesenchymal tumor cell line:LI90	10778-110G4	29.62	1.85	2.47	1.54	2.16	1.85	0.93	1.54
hepatoblastoma cell line:HuH-6	10633-108I3	61.84	0.00	0.00	2.38	1.19	1.19	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	49.28	11.16	1.44	2.98	1.77	2.21	1.22	0.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	55.47	12.99	1.82	3.52	2.67	1.21	0.36	1.46
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	54.16	11.92	2.83	3.74	2.12	1.11	1.31	0.81
hepatoma cell line:Li-7	10484-107A7	27.36	3.67	0.44	0.33	0.67	0.22	0.00	0.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	100.80	12.06	2.11	5.33	2.71	2.01	1.11	2.81
hippocampus - adult, donor10196	10169-103B7	71.92	19.87	3.79	0.00	7.57	0.95	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	106.74	23.06	3.67	1.63	4.90	0.00	0.82	0.61
hippocampus, adult, donor10258	10374-105G5	27.89	24.40	3.98	0.00	3.98	0.50	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	43.71	8.11	1.76	1.76	4.93	1.76	0.35	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	61.03	6.71	4.88	26.86	3.05	7.32	6.71	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	41.63	4.32	4.52	19.05	1.18	4.71	4.91	1.37
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	41.89	7.87	5.08	25.64	3.30	6.86	6.09	1.78
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	29.88	6.20	2.26	2.82	1.69	1.13	0.00	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	45.45	6.20	1.03	2.84	3.61	2.32	0.26	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	44.03	5.31	2.28	3.42	2.28	1.90	0.76	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	48.46	7.30	2.92	2.04	4.67	1.17	0.29	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	42.22	6.25	2.15	1.72	3.02	0.65	0.86	2.15
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	43.38	3.75	0.83	2.50	3.75	0.83	0.42	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	41.91	6.39	3.08	2.84	2.84	0.95	1.18	2.60
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	39.70	3.70	1.13	1.93	3.38	0.80	0.48	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	41.74	4.71	4.04	3.37	4.71	1.35	1.35	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	33.02	4.85	3.13	16.43	0.78	4.69	5.32	1.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	25.55	4.42	2.95	14.74	1.97	4.91	6.39	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	39.27	11.35	6.11	20.07	0.87	9.60	2.62	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	54.79	6.87	0.95	0.76	3.25	1.34	0.38	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	51.46	6.11	1.31	1.31	1.74	0.87	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	51.48	10.99	1.00	1.50	2.00	1.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	31.65	3.01	1.51	0.94	3.96	0.38	0.00	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	31.83	6.82	0.91	0.91	2.73	0.45	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	32.26	2.82	0.94	0.94	5.01	0.94	0.00	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	34.78	2.45	1.14	1.31	1.63	0.33	0.65	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	26.13	5.52	0.87	0.29	2.32	0.29	0.58	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	26.60	4.18	2.99	2.09	3.89	0.30	0.60	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	57.64	7.57	4.99	16.07	2.40	4.43	4.06	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	47.64	4.85	3.14	16.26	2.00	4.28	3.42	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	66.55	6.53	4.49	14.70	4.08	11.02	4.49	2.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	34.15	5.63	2.11	2.82	2.46	0.70	0.35	1.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	38.01	3.80	2.53	2.22	3.48	0.32	0.00	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	39.34	4.54	2.12	3.33	4.24	1.82	0.30	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	42.92	6.72	2.59	0.00	4.65	2.07	0.52	2.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	36.53	5.31	1.99	2.66	3.32	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	37.97	4.36	1.54	2.82	1.54	0.51	1.03	1.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	38.09	5.37	1.53	1.28	2.56	0.00	0.00	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	41.65	6.82	1.51	2.27	2.27	0.00	1.51	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	36.63	5.04	2.69	1.34	2.35	1.34	0.34	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	44.44	7.49	4.59	13.04	2.66	6.04	4.11	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	57.04	7.58	4.46	11.14	1.34	7.13	3.57	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	56.59	7.32	2.93	16.10	3.41	4.88	3.41	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	36.98	5.20	1.22	3.06	3.97	0.92	0.31	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	208.21	71.57	6.51	3.25	22.77	3.25	0.00	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	64.86	9.60	3.97	0.99	5.63	1.99	1.99	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	30.65	2.74	3.83	2.19	3.28	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	41.98	5.07	2.90	0.72	2.90	0.36	0.36	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	24.56	3.56	1.42	0.36	2.49	1.78	0.36	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	31.03	10.74	3.58	1.19	1.19	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	40.76	5.42	2.30	1.49	1.22	0.14	0.14	2.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	32.06	3.23	2.42	1.08	2.96	0.27	1.35	0.27
immature langerhans cells, donor1	11904-125F5	20.58	11.14	1.45	2.18	1.21	1.21	0.73	2.18
immature langerhans cells, donor2	11905-125F6	36.44	6.34	1.58	3.17	0.79	2.38	0.79	1.58
insula, adult, pool1	10039-101F3	81.95	22.62	2.56	1.23	2.65	0.09	0.19	1.51
keratoacanthoma cell line:HKA-1	10791-110H8	25.36	7.15	2.60	2.60	0.98	1.30	0.98	0.65
kidney, adult, pool1	10017-101C8	46.86	12.52	2.60	1.40	2.60	0.50	0.30	1.30
kidney, fetal, pool1	10045-101F9	23.41	4.17	1.20	1.20	1.27	0.35	0.07	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	32.38	2.98	2.98	1.42	1.56	0.43	0.14	1.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	28.89	4.29	0.55	0.41	0.41	0.28	0.14	1.38
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	29.18	2.75	1.28	1.28	2.20	0.55	0.00	0.37
left atrium, adult, donor1	10079-102A7	24.52	7.63	2.18	0.54	2.18	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	39.95	6.07	1.01	0.51	4.05	0.00	0.51	2.53
leiomyoblastoma cell line:G-402	10721-110A1	36.39	3.83	3.01	3.56	3.01	1.64	1.09	0.55
leiomyoma cell line:10964C	10569-108B2	8.26	2.51	1.44	1.80	1.44	1.44	0.72	0.36
leiomyoma cell line:15242A	10570-108B3	14.13	0.54	1.09	3.26	0.54	2.72	0.00	0.54
leiomyoma cell line:15425	10571-108B4	16.27	3.64	3.16	1.21	1.21	1.21	1.46	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	6.35	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	19.87	4.18	1.05	0.00	0.00	0.00	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	33.17	11.45	0.35	0.24	0.47	0.24	0.00	1.30
liposarcoma cell line:KMLS-1	10782-110G8	26.24	6.09	1.87	0.94	1.09	0.31	0.62	1.41
liposarcoma cell line:SW 872	10726-110A6	22.17	5.73	1.83	0.97	0.85	0.73	0.37	0.97
liver, adult, pool1	10018-101C9	23.66	6.81	3.73	0.97	3.08	0.32	0.65	0.49
liver, fetal, pool1	10086-102B5	21.64	0.94	0.94	0.94	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	80.79	9.62	4.37	0.87	6.27	0.87	0.44	1.31
locus coeruleus, adult, donor10252	10165-103B3	104.82	11.26	4.24	1.66	5.91	0.74	0.37	0.37
locus coeruleus, adult, donor10258	10375-105G6	47.40	7.90	2.26	0.56	4.51	1.97	0.00	1.41
locus coeruleus, newborn, donor10223	10362-105F2	58.89	17.67	2.52	1.26	6.31	1.68	2.10	0.84
lung adenocarcinoma cell line:A549	10499-107C4	19.93	5.81	0.55	2.21	0.28	0.14	0.14	1.25
lung adenocarcinoma cell line:PC-14	10408-106B3	36.54	8.27	2.07	2.07	5.52	0.69	0.00	2.07
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	26.36	6.06	2.64	0.66	0.66	1.05	0.13	0.26
lung, adult, pool1	10019-101D1	25.04	3.66	2.60	1.42	1.77	0.59	0.24	1.54
lung, fetal, donor1	10068-101I5	64.22	16.27	7.99	1.14	6.28	0.00	1.43	2.28
lung, right lower lobe, adult, donor1	10075-102A3	41.24	5.50	1.83	1.83	5.04	0.92	0.46	0.46
lymph node, adult, donor1	10077-102A5	24.61	4.26	1.42	1.42	1.89	0.95	1.42	0.00
lymphangiectasia cell line:DS-1	10727-110A7	30.68	4.38	1.10	1.75	1.53	1.53	0.22	3.73
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	60.37	17.36	1.66	1.06	2.11	1.21	0.45	2.41
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	45.87	5.95	0.85	0.00	1.70	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	27.08	10.66	4.44	2.22	4.44	1.33	0.44	0.44
mature adipocyte, donor2	12232-129F9	34.24	6.23	4.77	1.04	3.74	0.62	0.62	0.42
mature adipocyte, donor3	12233-129G1	28.21	9.72	3.56	1.42	1.90	0.71	0.00	0.71
mature adipocyte, donor4	12234-129G2	40.27	10.53	2.37	1.32	3.42	0.26	0.53	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	39.31	5.72	3.34	0.24	1.91	0.48	0.00	2.62
medial frontal gyrus - adult, donor10196	10170-103B8	62.04	19.18	3.38	2.26	6.77	0.00	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	118.07	26.11	3.31	1.29	8.28	0.55	0.18	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	48.92	17.16	2.86	0.32	3.81	0.32	0.95	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	95.96	33.69	4.69	2.99	5.97	0.43	0.43	2.56
medial temporal gyrus - adult, donor10196	10183-103D3	74.25	21.26	2.19	0.51	7.93	0.34	0.34	1.69
medial temporal gyrus, adult, donor10252	10156-103A3	113.96	34.80	2.12	1.06	5.94	0.21	0.00	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	21.19	17.34	3.85	0.00	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	157.89	172.24	0.00	0.00	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	53.84	16.51	5.38	1.44	4.31	1.08	0.36	1.44
medulla oblongata - adult, donor10196	10174-103C3	51.27	13.63	2.60	0.65	5.84	0.00	0.00	1.95
medulla oblongata, adult, donor10252	10155-103A2	102.17	13.78	3.41	0.93	4.02	0.31	0.62	0.93
medulla oblongata, adult, pool1	10038-101F2	55.59	11.43	2.94	0.57	3.59	0.57	0.33	1.47
medulla oblongata, newborn, donor10223	10361-105F1	51.38	6.25	8.68	2.43	2.43	0.35	1.74	0.69
medulloblastoma cell line:D283 Med	10838-111E1	62.88	10.85	1.11	1.33	1.11	0.44	0.22	0.66
medulloblastoma cell line:ONS-76	10759-110E3	29.96	3.30	0.98	0.86	1.35	1.10	0.37	0.98
melanoma cell line:COLO 679	10514-107E1	21.27	5.03	1.01	0.29	0.57	0.43	0.43	2.01
melanoma cell line:G-361	10465-106H6	17.65	4.61	1.36	0.81	1.63	0.27	0.00	0.54
meningioma cell line:HKBMM	10691-109F7	30.75	3.62	0.36	1.09	1.81	0.18	0.54	0.72
merkel cell carcinoma cell line:MKL-1	10843-111E6	46.70	14.10	2.64	2.64	3.52	0.88	1.76	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	61.70	10.11	3.11	3.11	2.59	2.07	1.30	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	55.39	9.21	2.15	3.53	2.30	1.99	0.77	2.30
mesenchymal precursor cell - adipose, donor2	11748-123G2	28.72	4.18	1.27	1.64	2.91	0.55	0.91	1.64
mesenchymal precursor cell - adipose, donor3	11749-123G3	17.81	4.56	2.48	2.90	1.66	1.66	0.41	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	23.46	3.09	1.69	3.09	1.55	1.40	0.28	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	24.07	2.31	2.89	4.24	1.93	0.77	1.54	1.35
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	18.74	4.86	5.55	4.86	2.08	2.08	2.78	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	19.39	2.23	3.26	3.43	1.20	1.37	0.69	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	24.61	3.34	1.96	2.42	1.84	0.92	0.69	0.69
mesenchymal precursor cell - cardiac, donor3	11754-123G8	36.08	6.50	1.86	3.05	1.46	1.72	2.25	2.65
mesenchymal precursor cell - cardiac, donor4	11755-123G9	39.16	6.21	2.16	7.97	2.84	3.11	2.70	1.49
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	34.57	5.98	3.13	8.25	1.42	2.56	3.41	0.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	20.75	1.98	1.65	1.65	0.66	0.66	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	37.64	3.60	2.63	4.70	2.35	2.49	3.60	0.83
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	33.51	5.93	3.49	3.84	2.09	1.75	1.05	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	23.89	4.08	3.06	2.45	1.84	1.63	0.61	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	17.61	1.44	2.88	2.88	1.44	0.72	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	16.24	1.97	1.55	2.90	1.24	1.55	0.93	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	12.54	1.14	2.05	4.10	1.37	2.51	2.28	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	46.57	10.49	5.03	10.49	4.20	1.26	2.52	3.36
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	37.36	4.78	1.94	3.59	2.09	1.05	1.49	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	24.33	1.93	2.19	7.88	2.36	2.45	3.06	0.88
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	21.72	5.89	1.47	3.31	0.74	1.10	1.84	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	20.03	2.00	1.72	3.43	1.43	0.57	0.86	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	34.10	8.42	0.84	3.79	2.11	2.11	0.42	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	19.18	5.48	0.46	2.74	2.28	1.37	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	19.70	5.37	2.30	1.53	2.30	1.28	0.51	1.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	20.68	7.33	2.36	1.57	2.09	0.26	0.52	1.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	18.18	6.16	1.54	0.92	1.85	0.31	0.92	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	19.53	6.59	2.12	0.71	2.35	0.24	0.47	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	17.94	2.03	2.03	2.71	2.03	0.34	0.68	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	24.76	5.11	3.14	1.57	0.79	0.00	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	19.93	3.24	3.71	0.46	1.85	0.93	0.46	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	27.69	6.35	2.88	2.31	2.60	0.87	0.58	2.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	21.86	4.46	0.89	2.90	1.34	1.34	0.22	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	25.72	5.05	1.20	0.72	1.20	1.44	0.24	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	30.80	8.07	2.20	3.67	4.40	2.93	2.93	2.93
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	18.80	5.71	2.01	0.34	2.01	0.34	0.00	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	23.33	5.32	2.05	0.82	0.41	0.82	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	23.20	5.58	3.01	0.43	2.15	0.86	0.43	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	8.20	2.73	0.00	0.00	2.73	0.00	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	20.66	10.33	0.00	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	22.41	7.15	2.27	2.60	1.95	2.27	0.32	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	21.82	7.27	1.45	1.45	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	18.66	8.00	2.67	2.13	1.60	1.07	1.07	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	26.99	2.45	0.82	2.45	3.27	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	20.21	4.66	1.55	1.17	1.55	0.39	0.39	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	23.09	2.10	2.10	4.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	17.88	3.97	0.99	0.99	1.99	1.99	1.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	14.30	0.00	0.00	4.77	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	14.82	4.15	1.78	0.59	2.37	1.19	1.19	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	21.93	12.18	0.00	2.44	0.00	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	25.34	5.07	1.27	1.90	0.63	0.63	0.00	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	26.21	5.86	1.72	1.38	2.07	0.34	0.34	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	19.34	2.15	6.45	0.00	0.00	4.30	0.00	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	11.98	3.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	3.44	0.00	0.00	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	23.23	4.48	2.44	0.41	1.22	0.41	0.00	2.85
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	12.71	1.59	0.79	0.79	0.79	0.00	0.79	3.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	10.61	1.77	1.77	0.59	1.18	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	12.78	2.18	2.18	0.00	0.62	0.00	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	20.05	5.35	1.34	0.00	4.01	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	15.37	2.37	1.18	0.00	2.37	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	20.54	5.14	5.14	0.00	2.57	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	24.09	4.13	4.13	0.69	2.07	0.00	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	15.34	1.98	4.95	0.99	0.49	0.99	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	12.34	3.36	0.00	2.24	2.24	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	14.63	4.45	1.91	1.27	0.00	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	10.88	2.42	3.22	1.21	0.81	0.81	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	15.26	0.00	2.18	0.00	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	3.80	1.27	0.00	2.53	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	10.92	3.03	3.64	3.03	1.21	1.82	0.00	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	0.00	0.00	0.00	0.00	0.00	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	12.36	4.12	4.12	2.47	2.47	0.00	0.82	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	17.26	3.37	4.17	2.58	1.19	0.99	1.39	0.99
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	13.30	5.52	1.95	0.97	1.30	1.30	0.00	1.95
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	9.17	4.07	4.07	0.00	1.02	1.02	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	24.76	3.09	3.09	0.00	3.87	0.00	0.77	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	43.47	4.25	1.65	1.65	1.42	1.42	0.00	2.83
mesothelioma cell line:ACC-MESO-4	10494-107B8	12.97	3.24	1.16	0.00	0.70	0.00	0.23	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	28.05	4.21	0.62	0.51	1.34	0.62	0.21	0.41
mesothelioma cell line:Mero-25	10850-111F4	9.99	1.59	0.45	0.45	0.68	0.68	0.45	2.04
mesothelioma cell line:Mero-41	10851-111F5	19.07	8.56	4.16	2.20	1.47	0.73	1.22	0.98
mesothelioma cell line:Mero-48a	10852-111F6	19.93	5.54	2.44	0.66	1.11	0.66	0.22	0.22
mesothelioma cell line:Mero-82	10853-111F7	17.61	5.78	0.79	1.58	1.31	0.26	0.26	1.31
mesothelioma cell line:Mero-83	10854-111F8	24.51	3.92	1.19	1.53	1.36	0.17	0.17	1.19
mesothelioma cell line:Mero-84	10855-111F9	12.89	4.04	0.76	2.02	1.01	0.51	1.77	0.76
mesothelioma cell line:Mero-95	10856-111G1	10.77	3.73	1.24	2.28	1.45	0.41	0.83	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	17.72	3.81	1.49	1.33	0.33	0.83	0.17	0.66
mesothelioma cell line:NCI-H226	10846-111E9	38.37	11.40	1.45	3.62	2.17	1.09	0.36	1.45
mesothelioma cell line:NCI-H2452	10848-111F2	17.77	5.47	1.20	1.02	1.02	0.68	0.00	0.68
mesothelioma cell line:NCI-H28	10845-111E8	44.28	7.13	2.80	1.78	2.29	1.02	1.53	2.80
mesothelioma cell line:No36	10857-111G2	16.64	3.59	1.63	0.65	1.30	0.00	0.65	0.33
mesothelioma cell line:ONE58	10858-111G3	18.15	4.06	1.35	1.35	1.08	0.27	0.54	0.81
migratory langerhans cells, donor1	11901-125F2	25.53	4.61	2.11	2.30	2.11	1.15	0.77	0.38
migratory langerhans cells, donor2	11902-125F3	24.55	3.91	2.56	3.54	2.32	0.61	1.95	0.61
migratory langerhans cells, donor3	11903-125F4	38.59	7.18	3.59	3.77	2.69	1.08	0.72	2.69
mixed mullerian tumor cell line:HTMMT	10689-109F5	49.62	3.59	2.29	0.33	2.94	0.33	0.98	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	22.68	4.24	0.64	1.48	1.27	1.27	0.85	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	66.34	5.76	3.69	4.15	2.07	3.92	1.15	1.15
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	39.39	4.95	0.95	2.66	0.38	1.14	0.76	2.47
myelodysplastic syndrome cell line:SKM-1	10772-110F7	59.69	10.72	1.11	1.48	2.03	0.74	0.00	3.14
myeloma cell line:PCM6	10474-106I6	33.21	3.95	0.59	2.17	1.78	0.20	0.40	5.34
myxofibrosarcoma cell line:MFH-ino	10600-108E6	20.80	3.04	2.54	2.03	1.52	2.03	0.51	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	31.58	9.61	3.33	2.55	1.57	1.96	0.78	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	13.93	2.01	2.34	2.56	0.67	1.67	1.00	0.89
nasal epithelial cells, donor1, tech_rep2	12226-129F3	15.15	2.21	1.76	2.79	1.03	1.32	1.18	0.66
nasal epithelial cells, donor2	12227-129F4	15.46	3.31	1.10	1.66	0.55	0.55	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	62.35	16.79	1.61	0.46	1.61	0.00	0.46	2.76
neuroblastoma cell line:NB-1	10539-107G8	61.93	13.84	2.81	6.92	2.25	1.68	2.06	1.50
neuroblastoma cell line:NBsusSR	10607-108F4	112.61	11.81	2.11	1.69	1.90	0.63	0.21	1.48
neuroblastoma cell line:NH-12	10555-107I6	52.92	9.50	1.68	0.56	2.61	0.75	0.37	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	144.23	6.64	1.66	3.08	3.56	0.24	1.19	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	68.58	7.92	1.74	2.69	2.53	1.27	1.11	2.38
neuroectodermal tumor cell line:TASK1	10774-110F9	41.06	5.43	1.61	2.42	1.61	0.81	0.20	1.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	80.74	6.99	3.81	3.81	4.45	1.27	1.91	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	28.75	5.59	2.40	1.60	1.06	0.80	0.80	1.86
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	76.27	23.17	1.52	0.85	3.04	0.68	0.34	2.37
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	32.02	8.81	1.60	1.60	1.60	0.80	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	22.44	4.81	0.96	1.92	1.28	0.96	0.64	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	32.32	6.31	1.58	2.63	2.36	1.84	0.53	1.84
nucleus accumbens, adult, pool1	10037-101F1	67.59	20.25	3.09	1.41	3.00	0.28	0.37	1.50
occipital cortex - adult, donor10196	10172-103C1	76.23	26.78	6.18	4.12	8.24	0.00	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	125.59	23.88	2.95	0.81	4.83	1.34	0.27	1.07
occipital cortex, newborn, donor10223	10355-105E4	59.69	15.65	3.28	1.82	2.55	0.73	0.36	2.18
occipital lobe, adult, donor1	10076-102A4	68.75	14.17	2.36	1.05	5.51	0.79	0.26	2.10
occipital lobe, fetal, donor1	10073-102A1	85.82	10.73	4.72	0.43	10.30	0.86	1.29	2.15
occipital pole, adult, pool1	10036-101E9	25.15	7.10	0.71	0.63	1.26	0.08	0.00	0.55
olfactory region, adult	10195-103E6	61.14	10.13	3.06	0.96	6.11	0.57	0.19	0.76
optic nerve, donor1	10277-104E7	136.07	22.01	6.00	2.00	8.00	0.00	2.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	25.06	5.13	0.57	1.03	0.80	0.46	0.11	1.37
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	77.35	8.52	2.06	1.24	0.96	0.82	0.00	2.34
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	29.46	6.77	2.37	3.39	1.52	1.69	1.19	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	29.92	6.70	0.69	0.58	0.81	0.35	0.46	3.12
osteoclastoma cell line:Hs 706.T	10704-109H2	32.34	5.00	1.47	2.35	2.35	1.18	0.88	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	78.48	8.41	0.93	0.93	3.74	0.00	0.00	4.67
osteosarcoma cell line:HS-Os-1	10558-107I9	38.17	8.27	1.06	1.48	1.48	0.85	0.64	1.48
ovary, adult, pool1	10020-101D2	31.53	4.80	2.53	1.92	1.75	0.70	0.79	0.96
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	21.45	1.65	0.37	2.38	1.10	1.10	0.55	0.18
pancreas, adult, donor1	10049-101G4	25.40	6.58	2.82	0.94	6.58	0.00	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	45.01	8.11	0.84	3.35	2.24	0.28	0.28	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	23.51	5.62	0.68	0.51	0.51	0.17	0.17	1.87
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	32.95	2.81	0.83	1.32	1.32	0.83	0.00	1.49
paracentral gyrus, adult, pool1	10035-101E8	58.48	17.57	2.29	0.73	3.11	0.09	0.18	1.28
parietal cortex, adult, donor10258	10373-105G4	28.63	13.21	2.20	0.73	4.40	0.73	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	50.79	17.87	3.76	0.94	7.52	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	103.47	22.52	3.71	1.71	6.56	0.29	0.00	0.57
parietal lobe, adult, pool1	10034-101E7	61.77	17.54	2.38	0.88	3.17	0.35	0.18	1.06
parietal lobe, fetal, donor1	10072-101I9	76.62	9.70	3.88	5.82	6.79	4.85	0.97	0.97
parietal lobe, newborn, donor10223	10356-105E5	52.34	18.69	2.62	1.50	2.62	0.00	1.12	1.87
parotid gland, adult	10199-103F1	26.52	4.93	7.40	0.62	1.85	0.00	0.00	1.23
penis, adult	10200-103F2	29.00	9.67	3.22	0.00	3.22	1.07	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	55.22	9.85	1.12	0.19	1.67	0.00	0.00	3.35
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	29.28	6.12	1.75	1.75	1.02	1.60	0.29	1.60
pineal gland - adult, donor10196	10179-103C8	36.77	7.10	1.94	0.65	3.87	0.00	0.65	1.29
pineal gland, adult, donor10252	10160-103A7	90.61	12.44	2.96	1.18	8.88	2.37	0.59	1.18
pineal gland, adult, donor10258	10377-105G8	37.00	10.03	5.02	0.00	5.02	0.63	0.63	1.25
pituitary gland - adult, donor10196	10180-103C9	77.91	10.12	6.07	6.07	12.14	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	169.90	16.68	15.64	4.17	11.47	0.52	2.08	2.08
pituitary gland, adult, donor10258	10378-105G9	61.29	17.02	9.36	5.11	5.11	1.70	2.55	0.00
placenta, adult, pool1	10021-101D3	27.20	8.28	2.58	0.86	1.94	0.54	0.11	0.75
plasma cell leukemia cell line:ARH-77	10840-111E3	59.72	6.75	1.85	1.99	2.25	1.06	0.13	1.46
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	24.90	3.89	2.33	0.31	1.87	0.00	0.16	0.00
pons, adult, pool1	10033-101E6	74.10	13.60	2.50	1.20	3.96	0.43	0.26	1.12
postcentral gyrus, adult, pool1	10032-101E5	38.53	11.51	1.13	0.52	2.44	0.00	0.09	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	25.10	4.18	2.09	0.00	4.18	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	0.00	0.00	0.00	5.51	0.00	0.00	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	33.07	5.24	0.87	2.91	1.02	0.58	0.29	1.75
prostate cancer cell line:PC-3	10439-106E7	34.12	8.17	0.91	2.00	2.00	0.91	1.27	2.72
prostate, adult, pool1	10022-101D4	34.46	6.62	2.90	1.36	2.90	0.27	0.09	0.63
putamen, adult, donor10196	10176-103C5	108.35	37.06	4.25	2.12	8.03	0.24	0.24	1.42
putamen, adult, donor10252	10152-102I8	96.08	19.61	0.00	1.96	0.00	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	31.69	30.60	8.74	4.37	2.19	1.09	2.19	3.28
putamen, adult, donor10258, tech_rep2	10372-105G3	49.05	27.30	3.14	1.69	2.90	1.21	0.97	0.24
putamen, newborn, donor10223	10365-105F5	67.47	28.49	7.50	3.75	9.00	3.00	3.75	1.50
rectal cancer cell line:TT1TKB	10469-106I1	93.68	7.86	1.75	0.87	0.29	1.16	0.00	1.45
rectum, fetal, donor1	10067-101I4	66.77	8.35	5.56	1.39	6.95	0.00	5.56	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	40.49	7.42	3.60	4.24	1.91	1.48	1.06	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	26.92	1.24	0.41	0.83	0.00	0.41	0.00	0.41
retina, adult, pool1	10030-101E3	33.00	11.93	1.69	1.09	1.39	0.20	0.20	1.49
retinoblastoma cell line:Y79	10475-106I7	33.77	8.05	1.82	1.04	3.12	0.52	0.00	3.12
rhabdomyosarcoma cell line:KYM-1	10787-110H4	39.22	5.29	1.72	3.44	0.86	0.98	0.37	0.86
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	54.83	4.78	1.97	0.56	3.37	0.28	0.00	3.66
sacrococcigeal teratoma cell line:HTST	10695-109G2	31.07	4.55	2.27	6.06	2.27	0.00	0.76	0.76
salivary acinar cells, donor1	11771-123I7	27.19	7.77	1.78	0.97	1.62	0.16	0.65	0.97
salivary acinar cells, donor2	11772-123I8	23.13	6.75	0.69	0.83	1.38	0.41	0.14	1.10
salivary acinar cells, donor3	11773-123I9	31.78	3.97	0.66	1.32	2.65	0.66	0.00	1.32
salivary gland, adult, pool1	10093-102C3	17.73	4.58	9.15	2.29	4.00	1.14	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	47.64	4.55	3.04	6.15	2.11	1.60	1.77	2.45
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	44.08	2.59	4.70	4.47	1.65	2.00	1.18	2.70
seminal vesicle, adult	10201-103F3	31.74	2.65	5.29	0.53	5.82	0.00	0.00	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	30.85	12.15	2.92	0.24	2.19	0.73	0.24	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	18.62	3.77	0.50	2.01	1.76	1.01	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	31.11	15.05	4.01	4.01	4.01	2.01	3.01	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	16.66	1.88	1.61	0.27	1.48	0.27	0.13	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	61.45	8.07	1.99	1.22	0.77	0.44	0.22	1.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	26.58	12.13	0.65	0.90	1.03	0.13	0.00	1.16
skeletal muscle - soleus muscle, donor1	10282-104F3	52.49	8.51	3.55	0.00	4.97	0.71	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	29.74	9.24	2.04	0.48	2.16	0.24	0.24	0.60
skeletal muscle, fetal, donor1	10066-101I3	19.10	2.01	0.00	1.01	3.02	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	13.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	37.24	9.47	4.42	0.63	6.94	1.26	0.00	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	31.68	4.67	3.67	3.00	1.67	1.67	1.33	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	24.27	6.30	2.84	1.26	1.89	0.32	0.00	1.58
small cell lung carcinoma cell line:DMS 144	10841-111E4	52.81	5.40	4.05	2.70	6.75	1.73	0.77	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	50.77	17.97	1.48	1.65	0.99	0.33	0.16	5.27
small cell lung carcinoma cell line:NCI-H82	10842-111E5	94.42	5.31	3.70	4.99	4.50	1.29	0.16	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	15.69	6.10	0.87	0.00	0.22	0.22	0.00	0.44
small intestine, adult, pool1	10024-101D6	37.03	9.79	3.58	2.87	2.87	0.72	1.91	0.84
small intestine, fetal, donor1	10064-101I1	26.78	4.91	1.72	1.97	2.21	0.49	0.98	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	23.08	1.54	1.03	1.03	1.54	0.00	0.51	0.51
smooth muscle, adult, pool1	10048-101G3	32.57	6.20	2.84	1.03	2.84	0.78	0.52	0.52
somatostatinoma cell line:QGP-1	10781-110G7	23.05	5.09	1.07	0.80	1.61	0.27	0.27	1.07
spinal cord - adult, donor10196	10181-103D1	73.41	8.03	2.06	2.06	9.18	0.00	0.23	1.61
spinal cord, adult, donor10252	10159-103A6	87.13	14.19	1.18	1.18	4.73	0.00	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	26.29	17.99	4.15	1.38	4.15	0.69	0.69	2.77
spinal cord, fetal, donor1	10056-101H2	59.76	7.32	2.44	1.22	5.49	1.22	0.00	1.22
spinal cord, newborn, donor10223	10359-105E8	82.66	10.56	5.51	5.05	6.43	0.92	0.00	3.67
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	30.47	4.93	3.29	4.78	1.19	1.79	1.19	1.05
spleen, adult, pool1	10025-101D7	27.42	6.61	1.65	0.77	2.42	0.55	0.66	1.98
spleen, fetal, pool1	10044-101F8	22.01	5.40	0.95	0.95	0.79	0.40	0.72	1.03
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	26.91	8.28	0.72	3.00	0.93	1.35	0.62	2.79
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	24.49	5.32	0.76	1.14	0.57	0.95	0.38	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	34.25	10.48	4.89	1.40	6.64	0.70	0.00	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	24.24	1.56	2.74	1.95	2.35	1.17	0.78	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	22.85	3.15	1.80	0.56	1.13	0.34	0.45	0.79
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	14.40	2.97	3.39	0.85	0.00	1.69	1.27	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	17.35	9.31	0.85	0.42	0.42	0.00	0.42	1.27
stomach, fetal, donor1	10062-101H8	45.92	13.88	0.00	1.07	2.14	0.00	0.00	3.20
submaxillary gland, adult	10202-103F4	23.36	6.27	3.99	0.57	5.13	0.00	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	271.37	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	97.62	14.75	4.36	1.04	4.98	0.21	0.62	1.25
substantia nigra, adult, donor10258	10371-105G2	30.00	13.97	3.62	0.52	5.69	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	41.69	7.77	6.36	2.12	4.24	0.00	0.00	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	47.92	11.92	1.15	1.38	2.06	0.23	0.92	1.38
temporal lobe, adult, pool1	10031-101E4	26.96	6.95	1.02	0.08	1.02	0.34	0.17	0.59
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	61.97	12.82	5.70	2.85	9.97	2.14	1.42	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	42.64	10.99	6.15	1.32	3.08	1.32	0.44	1.32
tenocyte, donor1	11763-123H8	18.50	3.84	3.84	2.79	5.24	2.09	3.14	0.70
tenocyte, donor2	11765-123I1	12.21	3.05	1.14	0.76	2.67	1.14	0.00	0.00
tenocyte, donor3	11768-123I4	22.61	2.97	4.08	3.34	1.48	0.74	1.85	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	64.92	9.01	3.06	10.37	3.74	2.38	2.38	2.04
teratocarcinoma cell line:NCR-G1	10798-110I6	36.38	5.09	1.08	2.00	1.08	1.08	0.15	1.54
teratocarcinoma cell line:PA-1	10807-111A6	59.05	3.10	1.55	3.10	2.63	2.17	0.46	1.24
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	47.22	6.47	1.90	2.54	2.92	2.03	0.89	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	47.27	7.19	2.27	1.51	2.27	0.38	1.13	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	75.69	5.45	3.49	4.91	4.80	0.98	0.22	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	71.65	11.40	2.93	3.91	6.84	0.98	0.98	0.98
testis, adult, pool1	10026-101D8	38.65	5.58	3.87	1.72	6.44	1.29	0.86	0.64
testis, adult, pool2	10096-102C6	33.83	5.41	9.02	2.26	8.57	0.90	1.35	2.26
thalamus - adult, donor10196	10168-103B6	52.99	6.62	6.62	1.10	1.10	2.21	3.31	0.00
thalamus, adult, donor10252	10154-103A1	121.59	21.41	5.78	1.09	7.97	0.47	1.09	1.25
thalamus, adult, donor10258, tech_rep1	10370-105G1	41.57	32.33	12.32	1.54	4.62	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	42.16	7.74	1.98	1.15	3.46	0.33	0.00	1.15
thalamus, newborn, donor10223	10366-105F6	44.87	13.81	4.03	2.30	1.15	1.73	0.00	2.30
throat, adult	10209-103G2	31.71	6.99	2.75	1.25	2.25	0.50	0.75	0.00
throat, fetal, donor1	10061-101H7	41.44	11.58	2.44	1.22	5.18	0.30	0.00	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	55.84	5.17	1.39	1.99	2.58	0.79	0.40	1.59
thymus, adult, pool1	10027-101D9	30.32	5.27	1.59	3.88	1.19	0.89	1.59	1.09
thymus, fetal, pool1	10043-101F7	44.47	5.51	1.87	2.49	1.45	0.94	1.45	2.29
thyroid carcinoma cell line:KHM-5M	10776-110G2	44.41	8.38	2.13	3.72	1.86	0.53	0.93	1.60
thyroid carcinoma cell line:TCO-1	10783-110G9	34.36	3.21	0.98	1.26	0.98	0.98	0.14	1.96
thyroid, adult, pool1	10028-101E1	51.70	6.81	3.64	0.84	3.73	0.19	0.28	1.21
thyroid, fetal, donor1	10060-101H6	50.89	7.91	5.01	0.26	5.27	1.05	0.79	1.85
tongue epidermis (fungiform papillae), donor1	10288-104F9	30.80	18.48	0.00	0.00	3.08	0.00	0.00	3.08
tongue, adult	10203-103F5	31.63	8.37	1.86	1.40	1.86	0.70	0.70	1.40
tongue, fetal, donor1	10059-101H5	39.41	10.25	2.36	1.58	1.97	0.79	0.00	0.39
tonsil, adult, pool1	10047-101G2	29.15	5.51	2.40	1.30	0.80	0.70	0.50	0.70
trachea, adult, pool1	10029-101E2	31.33	6.79	2.70	1.64	1.55	0.57	1.06	0.82
trachea, fetal, donor1	10058-101H4	32.31	5.77	0.77	1.54	4.23	1.54	0.00	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	29.76	7.09	2.83	4.61	1.77	3.54	1.42	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	25.13	6.69	0.61	1.01	0.61	0.81	0.71	0.71
transitional-cell carcinoma cell line:JMSU1	10492-107B6	45.44	5.64	1.57	2.82	2.66	0.94	0.00	2.35
tridermal teratoma cell line:HGRT	10694-109G1	58.98	1.90	1.90	1.90	3.81	5.71	1.90	7.61
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	23.53	5.93	1.02	0.68	0.76	0.34	0.34	2.71
umbilical cord, fetal, donor1	10057-101H3	18.78	8.35	0.00	0.00	4.17	2.09	2.09	2.09
uterus, adult, pool1	10100-102D1	25.25	11.09	4.27	2.90	4.10	1.02	1.19	0.68
uterus, fetal, donor1	10055-101H1	44.03	6.14	3.58	0.51	6.14	1.02	1.54	2.56
vagina, adult	10204-103F6	96.93	12.92	0.65	1.94	3.23	0.65	0.65	0.65
vein, adult	10191-103E2	22.80	7.01	2.85	1.10	3.51	0.22	0.22	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	24.83	8.28	0.53	1.60	1.60	0.53	0.27	2.67